Stent-valves for valve replacement and associated methods and systems for surgery

Description

FIELD OF THE INVENTION

Embodiments of the present invention relate to stent-valves, associated methods and systems for their delivery via minimally-invasive surgery, and guide-wire compatible closure devices for sealing access orifices.

BACKGROUND OF THE INVENTION

Conventional approaches for cardiac valve replacement require the cutting of a relatively large opening in the patient's sternum (“sternotomy”) or thoracic cavity (“thoracotomy”) in order to allow the surgeon to access the patient's heart. Additionally, these approaches require arrest of the patient's heart and a cardiopulmonary bypass (i.e., use of a heart-lung bypass machine to oxygenate and circulate the patient's blood). Despite their invasiveness, these surgical approaches may be reasonably safe for a first intervention. However, tissue adherences resulting from the first surgery may increase the risks (e.g., death) associated with subsequent valve replacement surgeries. See Akins et al., “Risk of Reoperative Valve Replacement for Failed Mitral and Aortic Bioprostheses”, Ann Thorac Surg 1998; 65:1545-52; and Weerasinghe et al., “First Redo Heart Valve Replacement—A 10-Year Analysis”, Circulation 1999; 99:655-658; each of which is incorporated by reference herein in its entirety.

Synthetic valves and biological valves have been used for cardiac valve replacement with varying results. Synthetic valves rarely fail but require life-long anti-coagulant treatment to prevent blood from clotting (thrombosis) in and around the replacement valve. Such anti-coagulant treatment significantly limits patients' activities and can cause various other complications. Biological valves do not require such anti-coagulation treatment but typically fail within 10-15 years. Thus, to limit the need for and risks associated with re-operation on failed biological valves, traditionally only patients with less than about 10-15 years to live have received biological valve replacements. Patients with longer life expectancies have received synthetic valves and anti-coagulant treatment.

Attempts have been made to develop less-invasive surgical methods for cardiac valve replacement. These surgical methods, referred to as percutaneous heart valve replacement therapies (PHVT), use a catheter to deliver a replacement valve to an implantation site using the patient's vascular system. These PHVT attempts have various shortcomings, including their inability to ensure proper positioning and stability of the replacement valve within the patient's body.

Conventional closure devices for closing access orifices are also lacking in several respects, including the looseness of their fit which can cause bleeding after surgery. These closure devices also lack a central lumen, which renders them incompatible with guide wire delivery systems. One such conventional closure device is described in Malgorzata Pawelec-Wojtalik, “Closure of left ventricle perforation with the use of muscular VSD occluder”, European Journal of Cardio-Thoracic Surgery 27 (2005) 714-716, which is incorporated by reference herein in its entirety.

In view of the foregoing, it would be desirable to provide improved methods, systems, and devices for cardiac valve replacement.

SUMMARY OF THE INVENTION

Some embodiments of the present invention are directed to systems, methods, and devices for cardiac valve replacement. For example, these methods, systems, and devices may be applicable to the full range of cardiac-valve therapies including the replacement of failed aortic, mitral, tricuspid, and pulmonary valves. In some embodiments, the present invention may facilitate a surgical approach whereby surgery is performed on a beating heart without the need for an open-chest cavity and heart-lung bypass. This minimally-invasive surgical approach may reduce the risks associated with replacing a failed native valve in the first instance, as well as the risks associated with secondary or subsequent surgeries to replace failed artificial (e.g., biological or synthetic) valves.

Stent-valves according to some embodiments of the present invention may include a valve component and at least one stent component. The valve component may include a biological or synthetic (e.g., mechanical) valve and/or any other suitable material(s). The stent component may include a first section (e.g., proximal section), a second section configured to house the valve component, and a third section (e.g., distal section). The stent and valve components may be capable of at least two configurations: a collapsed configuration (e.g., during delivery) and an expanded configuration (e.g., after implantation).

In some embodiments, the first section of the stent valve may include a fixation element. Such a fixation element may include, for example, an annular groove for securing the stent-valve in place at an implantation site. When the stent-valve includes a single stent (“single-stent-valve”), the annular groove may be configured to receive the annulus of the valve in need of replacement. When the stent-valve includes two stents (“double-stent-valve”), the annular groove of the first stent component may be configured for matable attachment to a complimentary annular projection of a second stent component (i.e., a positioning stent). In turn, the second stent component may be anchored at the implantation site, for example, to the valve in need of replacement and/or adjoining structures.

Alternatively or additionally, in some embodiments the third section of the stent component may include at least one attachment element. Each attachment element of the stent-valve may include, for example, a geometrical opening (e.g., circular or ovular), hook, or strap configured for removable attachment to a complimentary structure of a delivery device. In addition, each attachment element may correspond to all or a portion of a commisural post, to which a commissure between two valve leaflets may be attached. The attachment element(s) may allow the stent-valve to be partially expanded within a patient's body while the stent-valve remains attached to the delivery device. This may allow the stent-valve to be returned to a collapsed configuration and repositioned within the patient's body when it is determined that fully expanding the stent-valve would cause the stent-valve to be installed incorrectly. Alternatively or additionally, this may allow the stent-valve to be returned to the collapsed configuration and removed from the patient's body when it is determined that the stent-valve is not functioning properly (e.g., not permitting sufficient flow). In some embodiments, the stent-valve may include one attachment element. In other embodiments, the stent-valve may include at least two, three, six, or any other suitable number of attachment elements. In some embodiments, the fully-expanded stent diameter in the region of the attachment element(s) may be smaller than the diameter of the region that houses an associated valve. This may reduce the risk of injury to the patient's body (e.g., perforation of the aorta) from the attachment elements and/or make it easier to affix the attachment elements to the complimentary structure of the delivery device.

In some embodiments, the stent component of the stent-valve may include a lattice structure with a plurality of cells. The lattice structure may be formed from, for example, a shape-memory alloy such as nitinol or any other suitable material(s). The cells in the lattice structure may be most densely populated in the section of the stent component that includes the fixation element. This may provide added support to the fixation element and increase the stability of the stent-valve. In some embodiments, the lattice structure may form at least one elongate stem (e.g., commissural post) that extends distally along the stent component towards the at least one attachment element. The at least one stem may connect directly to the at least one attachment element. Alternatively, the lattice structure may form at least one supporting element for connecting the at least one stem to the at least one attachment element. In some embodiments, all of the cells in the lattice structure may be closed cells, which may facilitate recapture of the stent-valve from the partially-expanded configuration to the collapsed configuration.

Still other embodiments of the present invention are directed to a method for replacing a valve. A stent-valve is provided that includes a stent component with an annular groove, and the stent-valve is secured axially to an annulus of the valve in need of replacement. In some embodiments, providing a stent-valve may include suturing a valve component to the stent component. Alternatively or additionally, providing a stent-valve may include expanding a valve component within the stent component in order to form a friction fitting. In some embodiments, providing a stent-valve may include securing a valve component to the stent component with a hook-and-loop (e.g., VELCRO®) fastening system.

In other embodiments of the present invention, a method for replacing a valve is provided whereby a first stent component that includes an annular element is implanted such that at least a portion of the first stent component is housed within a valve in need of replacement. A stent-valve that includes a second stent component is positioned within the first stent component by matably attaching a complimentary annular element of the second stent component to the annular element of the first stent component.

In still other embodiments of the present invention, a stent-valve delivery system is provided. A first assembly is provided that includes an outer sheath and a guide wire tubing. The delivery system also includes a second assembly including a stent holder configured for removable attachment to at least one attachment element of a stent-valve. The stent-valve may be positioned over the guide wire of the first assembly. The first assembly and the second assembly may be configured for relative movement with respect to one another in order to transition from a closed position to an open position. In the closed position, the outer sheath may encompass the stent-valve still attached to the stent holder and thus constrain expansion of the stent-valve. In the open position, the outer sheath may not constrain expansion of the stent-valve and thus the stent-valve may detach from the stent holder and expand to a fully expanded configuration.

In some embodiments, the first assembly and the second assembly may be configured to transition from the closed position, to a partially-open position, to the open position. In the partially-open position, the stent-valve may expand partially but not detach from the stent holder because the outer sheath may still encompass the at least one attachment element of the stent-valve and the stent holder. When the stent-valve is in the partially-expanded configuration, it may be determined whether the stent-valve will be positioned correctly if the stent-valve is expanded to the fully expanded configuration. Alternatively or additionally, the functionality of the stent-valve may be tested (e.g., to determine whether the stent-valve will permit sufficient blood-flow) when the stent-valve is in the partially-expanded configuration.

In some embodiments, the stent-valve delivery system may include at least one balloon (e.g., proximal to the stent-valve or other stent to be delivered) configured to cause expansion of the stent-valve or positioning stent upon inflation of the at least one balloon.

In some embodiments, the stent-valve delivery system may include a push handle that causes the relative movement of the first assembly and the second assembly. Alternatively, the stent-valve delivery system may include a screw mechanism for translating rotational movement of a handle into the relative movement of the first assembly and the second assembly.

In some embodiments, the stent-valve delivery system may include an integrated introducer within which the first assembly and the second assembly are positioned during delivery of the stent-valve to an implantation site. The integrated introducer may be configured to remain within a patient's body even after the first assembly and the second assembly are removed, for example, to allow for the introduction of an occluder.

In some embodiments, after expansion of the stent-valve to the fully expanded configuration, the delivery system may be configured to return to the closed position by passing the second assembly through the stent-valve towards a distal end of the first assembly.

Still other embodiments of the present invention are directed to a method for delivering a stent-valve to an implantation site whereby the stent-valve is removably attached to a delivery device and the stent-valve is delivered to the implantation site in a collapsed configuration. The stent-valve may be partially expanded while maintaining the stent-valve attached to the delivery device. A determination with respect to the stent-valve may be made when the stent-valve is in the partially-expanded configuration. When the determination yields a positive response, the stent-valve may be expanded to its fully expanded configuration by causing the stent-valve to detach from the delivery device.

In one particular embodiment, it may be determined whether the stent-valve is positioned correctly at the implantation site. The stent-valve may be returned to the collapsed configuration and repositioned when the stent-valve is not positioned correctly at the implantation site.

Alternatively or additionally, it may be determined whether a valve component of the stent-valve is functioning properly, for example, by testing whether the valve component will permit sufficient blood-flow. The stent-valve may be returned to the collapsed configuration and removed from a patient's body when the stent-valve is not functioning properly.

In some embodiments, delivering the stent-valve to the implantation site may include delivering the stent-valve to the heart for replacement of a cardiac valve. The delivery may include accessing a patient's body through an intercostal space (e.g., fifth intercostal space) and penetrating the left ventricle at the apex of the heart.

In still other embodiments of the present invention, an occluder for sealing an orifice in tissue is provided. The occluder may include a first portion capable of expansion from a collapsed configuration on a luminal side of the orifice to an expanded configuration. The occluder also includes a second portion capable of expansion from a collapsed configuration to an expanded configuration on a side of the orifice opposite to the luminal side. The first portion and the second portion may form a central, hollow channel for housing a guide wire.

In some embodiments, the occluder may include a connector for connecting the occluder to a catheter. For example, the connector may include a hollow screw mechanism for connecting to a threaded catheter. The occluder may be housed by a second catheter for delivery to the tissue orifice.

In some embodiments, the top portion of the occluder may include a channel sealing mechanism for preventing blood-flow from the luminal side of the tissue orifice. For example, the channel sealing mechanism may include a membrane, foam, and/or a valve. Suitable examples of foam and/or membranous materials include polyurethane and gelatin.

In some embodiments, the top portion of the occluder may include a first material and the bottom portion of the occluder may include a second material, where the second material may be coarser than the first material. This may facilitate the formation of scar tissue on the outer portion and speed the heeling process. For example, the first and/or second materials may include felt(s) and/or velour(s) made from Teflon, Dacron, polyurethane, polydioxanone, polyhydroxybutyrate, and/or other material.

In other embodiments of the present invention, a method for sealing an orifice in tissue is provided whereby an expandable and collapsible occlusion device is connected to a first catheter. The occlusion device may be inserted into a second catheter in a collapsed condition. The first catheter and a central channel of the occlusion device may receive a guide wire. The second catheter may be positioned in the orifice, such that a first end of the second catheter is positioned on a luminal side of the orifice. Relative movement between the collapsed occlusion device and the second catheter may be caused in order to move the occlusion device out of the second catheter. Upon the occlusion device emerging from the first end of the second catheter, a first portion of the occlusion device may expand on the luminal side of the orifice. Upon the occlusion device being completely emerged from the second catheter, a second portion of the occlusion device may expand.

BRIEF DESCRIPTION OF THE DRAWINGS

For a better understanding of the present invention, reference is made to the following description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:

FIG. 1A shows a valve component in an expanded configuration according to some embodiments of the present invention;

FIG. 1B shows a valve component in a collapsed configuration according to some embodiments of the present invention;

FIG. 2A shows a stent component in an expanded configuration according to some embodiments of the present invention;

FIG. 2B shows a single-stent-valve, that includes a stent component and a valve component, in an expanded configuration according to some embodiments of the present invention;

FIG. 2C shows a single-stent-valve a collapsed configuration according to some embodiments of the present invention;

FIG. 3A shows a stent component in an expanded configuration according to some embodiments of the present invention;

FIG. 3B shows a stent component in a collapsed configuration according to some embodiments of the present invention;

FIG. 4 shows a double-stent-valve, that includes two stent components and a valve component, in an expanded configuration according to some embodiments of the present invention;

FIGS. 5A-7B illustrate the use of a single-stent-valve to replace a failed biological (artificial) valve according to some embodiments of the present invention;

FIGS. 8A and 8B show a stent component that includes attachment elements for securing the stent to a delivery device and fixation elements for securing the stent at the implantation site according to some embodiments of the present invention;

FIG. 8C shows a stent component having a diameter in the region of the attachment element(s) that is smaller than the diameter of a stent region that houses an associated valve, according to some embodiments of the present invention;

FIG. 8D shows a stent component that includes independently bendable element(s) for use in positioning/securing the stent to the geometry/topology at an implantation site according to some embodiments of the present invention;

FIG. 8E shows a stent component that includes locking elements in a crown configuration and a fixation element for securing the stent at an implantation site according to some embodiments of the present invention;

FIG. 8F shows a stent component that includes multiple struts for carrying a valve component more closely to a region of the stent component that includes attachment element(s) for attaching the stent component to a delivery device;

FIGS. 9A-16 show additional embodiments of stent components that include attachment elements for securing the stent to a delivery device and/or fixation elements for securing the stent at the implantation site according to the present invention;

FIGS. 17, 18, 19, and 20 show additional examples of double-stent-valves according to some embodiments of the present invention;

FIG. 21A shows a stent-valve in the shape of an opposed double crown according to some embodiments of the present invention;

FIGS. 21B-E show views of a double-conical stent in accordance with some embodiments of the present invention;

FIGS. 22A-22D show a delivery system for delivering a self-expanding stent-valve to an implantation site according to some embodiments of the present invention;

FIGS. 23A-23D show a delivery system with inflatable balloon(s) according to some embodiments of the present invention;

FIGS. 24A-24D show a delivery system having a proximal outer shaft with an increased diameter according to some embodiments of the present invention;

FIGS. 25A-25C show a delivery system with inflatable balloon(s) according to some embodiments of the present invention;

FIGS. 26A-26C show a delivery system with an integrated introducer according to some embodiments of the present invention;

FIG. 27 is a flowchart of illustrative stages involved in replacing a failed native or artificial valve according to some embodiments of the present invention;

FIGS. 28A-C illustrate the replacement of a failed valve through the use of a delivery system according to some embodiments of the present invention;

FIGS. 29A and 29B show a guide wire compatible occluder for sealing an access orifice according to some embodiments of the present invention;

FIG. 30 shows a guide wire for guiding the delivery of an occluder and/or stent-valve according to some embodiments of the present invention;

FIG. 31 shows a threaded catheter for attachment to and use in positioning an occluder according to some embodiments of the present invention;

FIGS. 32A and 32B show a delivery system for an occluder according to some embodiments of the present invention; and

FIGS. 33A and 33B show an occluder positioned within an access orifice according to some embodiments of the present invention.

DETAILED DESCRIPTION OF THE INVENTION

FIGS. 1A-3B show components 100, 200, and 300 for use in replacing, for example, a failed (e.g., degenerated) aortic valve, mitral valve, or pulmonary cardiac valve (e.g., in a pediatric patient) in accordance with some embodiments of the present invention. More particularly, FIGS. 1A and 1B show a valve component 100. FIGS. 2A-2C show a stent component 200 for housing valve component 100. FIGS. 3A and 3B show a stent component 300 for housing stent component 200 and valve component 100. A device that includes components 100 and 200 may be referred to as a single-stent-valve. A device that additionally includes component 300 may be referred to as a double-stent-valve.

FIG. 4 shows a double-stent-valve 400 that includes valve component 100, stent component 200, and stent component 300 in accordance with some embodiments of the present invention. Double-stent-valve 400 may replace a failed native or artificial valve. As used herein, a “native valve” refers to a valve naturally present within a patient's body. A failed native valve may be, for example, a stenotic valve. An “artificial valve” refers to a biological or synthetic (e.g., mechanical) valve introduced into the patient's body through surgery. The implantation site for a device 400 (or other replacement valve) typically includes at least a part of the area within the failed valve and/or along at least a portion of adjacent structure(s). For example, to replace a failed aortic valve, device 400 may be implanted within the patient's body such that portion 402 of the device is positioned substantially entirely within the failed aortic valve. Portion 404 of device 400 may extend along at least a portion of the aorta. Portion 406 of device 400 may extend into at least a portion of the left ventricle of the patient's heart.

Double-stent-valve 400 may be delivered to the implantation site using any suitable delivery approach. In some embodiments of the present invention, device 400 may be substantially entirely assembled from components 100, 200, and 300 outside the patient's body before device 400 is delivered to the implantation site. In other embodiments of the present invention, components 100, 200 and 300 of device 400 may be delivered to the implantation site separately in multiple steps. For example, stent component 300 may be delivered and installed at the implantation site, followed by the delivery and installation of stent component 200 and valve component 100 in one or more separate steps. In one embodiment, components 100 and 200 may be assembled outside the patient's body and then delivered and installed within component 300 at the same time. In another embodiment, stent component 200 may be delivered and installed within stent component 300, followed by the delivery and installation of valve component 100 in a separate step. Additional embodiments of double-stent-valves are described in connection with FIGS. 17-20.

In some embodiments of the present invention, a single-stent-valve (FIG. 2B) that includes valve component 100 and stent component 200 (but not stent component 300) may be used to replace a failed native or artificial valve. For example, in one particular embodiment, the single-stent-valve may replace a failed biological valve introduced to a patient's body during a prior valve replacement surgery. Thus, the surgery involving the single-stent-valve shown in FIG. 2B may be a secondary or subsequent valve replacement surgery. Although in this embodiment no new stent component 300 may be introduced to the patient's body, the single-stent-valve including components 100 and 200 may be housed by a stent and/or valve remaining at the implantation site from the prior valve replacement surgery. In some embodiments, at least a portion of the stent and/or valve from the prior surgery may be removed before the single-stent-valve is installed at the implantation site. Additional details regarding the replacement of a failed biological valve with a single-stent-valve are described in connection with FIGS. 5A-7B.

In some embodiments of the present invention, valve component 100 may be flexible and collapsible such that it can be collapsed, for example, during delivery via a catheter to the implantation site. Various embodiments of delivery systems and surgical approaches for minimally-invasive surgery are described below in connection with FIGS. 22-27C. Upon delivery, the valve component may be at least partially expanded. FIG. 1A is a perspective view of valve component 100 in an expanded configuration. FIG. 1B is a perspective view of valve component 100 in a collapsed configuration. As used herein, “collapsed configuration” and “expanded configuration” refer to a relative difference in, for example, the diameter and/or any other physical characteristic(s) of a component (e.g., length, width). For example, the collapsed valve component shown in FIG. 1B has an reduced diameter and may or may not have a longer length than the expanded valve component shown in FIG. 1A.

Valve component 100 may include a biological material (e.g., tanned, untanned, heterologous or autologous), non-biological material, a synthetic material (e.g., polymer(s) such as polyurethane and/or silicon(es)), or a combination thereof. In some embodiments, valve component 100 may include preserved biological tissue such as, for example, human tissue (e.g., homografts, autografts of valve tissue) or animal tissue (heterograft or xenograft valve tissue). In some embodiments, valve component 100 may be a mechanical valve. For example, when valve component 100 is a biological valve, expansion of valve component 100 from a collapsed configuration to an expanded may require self-expansion of an affixed stent component 200. In contrast, a synthetic valve component 100 may be capable of self-expansion. Valve component 100 may have a shape/form (e.g., length, width, diameter, etc.) corresponding to that of the intended valve application (e.g., tricuspid, pulmonary, mitral or aortic). In FIGS. 1A and 1B, valve component 100 is a tricuspid valve with three flaps. This particular configuration may be particularly suitable, for example, for replacing a failed aortic valve. In other embodiments, valve component 100 may have any other suitable number of flaps and/or other physical characteristics (e.g., diameter, length, width, etc.).

FIG. 2A is a perspective view of stent component 200 in accordance with an embodiment of the present invention. As shown in FIG. 2B, stent component 200 houses valve component 100. In some embodiments, at least a portion of stent component 200 may be substantially cylindrical in shape. Alternatively or additionally, stent component 200 may have an indentation (e.g., annular groove) or other fixation element 202, for example, for fixing the stent in place at the implantation site. For example, when stent component 200 is part of double-stent-valve 400 (FIG. 4), fixation element 202 may matably attach to a complimentary fixation element 302 (e.g., inward annular projection, FIG. 3A) of stent component 300. When stent component 200 is part of a single-stent valve (FIG. 2B), fixation element 202 may affix to at least a portion of the failed valve. Additional embodiments of stent components that may include fixation elements are described in connection with FIGS. 6A and 8A-16.

In some embodiments of the present invention, stent component 200, like valve component 100, may be capable of at least two configurations: a first, collapsed configuration (e.g., during delivery) and a second, expanded configuration (e.g., after installation). FIG. 2A shows stent component 200 in an illustrative expanded configuration. FIG. 2C shows stent component 200 in an illustrative collapsed configuration, with the collapsed valve component 100 housed therein, for example, for delivery of both components to the implantation site at the same time. In some embodiments, stent component 200 may be made from wire or may be laser cut from a tube, sheath, or the like. Stent component 200 may include a shape-memory alloy material such as, for example, nitinol. The shape-memory alloy may allow for compression of stent component 200 (and/or valve component 100) into the first configuration for, for example, delivery through a small opening in the patient's body and expansion of stent component 200 to the second configuration during installation. Components 100 and/or 200 may be held in the collapsed configuration, for example, with a sheath or wrap. The sheath/wrapping may be removed in order to allow components 100 and/or 200 to reconfigure into the second configuration.

Valve component 100 may be secured to stent component 200 via any suitable securing mechanism or combination of securing mechanisms. For example, in one embodiment, valve component 100 may be sutured with one or more stitches to stent component 200. In another embodiment, valve component 100 may be secured to stent component 200 by way of a friction fitting. For example, valve component 100 may have a fully-expanded diameter that is slightly larger than the expanded diameter of stent component 200 such that components 100 and 200 fit securely together upon expansion of component 100 within component 200. In yet another embodiment, a hook-and-loop type (e.g., VELCRO®) fastening system may be used to secure valve component 100 to stent component 200. For example, stent component 200 may include microscopic hooks and valve component 100 may include corresponding microscopic loops (or vice-versa). This hook-and-loop fastening system may include a micro-velour material, which has been used previously for surgical applications to improve tissue in-growth. Such a hook-and-loop fastening system may allow the position of valve component 100 to be fine-tuned relative to the position of stent component 200, for example, after components 100 and 200 have been implanted within a patient's body. The hooks/loops may also facilitate blood clotting and the formation of a seal at the interface between valve component 100 and stent component 200. To avoid premature clot formation (e.g., excessive clot formation before installation is complete), anti-coagulation monitoring and/or treatment may be provided to the patient. Reliable hook-and-loop connections may still be achieved in the presence of premature clot formation, although higher activation pressure (described below) may be required. A preliminary evaluation shows that reliable hook-and-loop connections can be formed in the presence of water, jelly, liquid soap, and/or coagulating proteins. In some embodiments, such a hook-and-loop fastening system may be used, alternatively or additionally, to secure stent component 200 to stent component 300 (e.g., with the microscopic hooks attached to an exterior surface of stent component 200 and the corresponding microscopic loops attached to an interior surface of stent component 300, or vice versa).

Any suitable mechanism or combination of mechanisms (e.g., direct or indirect exertion of mechanical compression) can be used to supply the activation pressure required to cause the micro-hooks to attach to the micro-loops. For example, in some embodiments, one or more balloons may be positioned adjacent to valve component 100 and/or stent component 200 (e.g., within valve component 100) and inflated temporarily to bring the micro-hooks into contact with the micro-loops. Such balloon(s) may placed within the valve component 100 and/or stent component 200 subsequent to delivery of the stent and/or valve to the implantation site. Alternatively, in some embodiments the balloon(s) can be mounted (e.g., removably mounted) within the valve component 100 and/or stent component 200 prior to delivery of the stent and/or valve to an implantation site (e.g., prior to loading the stent and/or valve into a delivery device). The use of such balloon(s) is not limited to embodiments in which the valve and stent are affixed to one another by way of hooks/loops. Rather, such balloon(s) may be used whenever it is necessary or desirable to use the balloon(s) to aid in the expansion and/or engagement at the implantation site of the stent and/or valve (e.g., when the valve is sutured to the stent). In some embodiments, a self-expanding valve component 100 may be provided that self-expands within stent component 200 in order to cause the micro-hooks to contact the micro-loops.

FIG. 3A is a perspective view of stent component 300 in accordance with an embodiment of the present invention. As described above, stent component 300 may have a fixation element 302 (e.g., inward annular projection) that matably attaches to a complimentary fixation element 202 of stent component 200 (FIG. 2A). FIG. 4 shows an embodiment of such matable attachment, in which component 300 houses both components 100 and 200 to form double-stent-valve 400. The geometry (e.g., length, width(s), diameter(s), etc.) of stent component 300 may be particularly suited, for example, for aortic valve replacement. In other embodiments, other geometries and configurations of stent component 300 may be provided.

Stent component 300 may be secured in place at the implantation site using any suitable securing mechanism or combination of securing mechanisms. For example, in some embodiments, fixation element 302 may form a recess (e.g., exterior annular groove) for receiving at least a portion of the failed valve. In some embodiments, stent component 300 may have a diameter slightly larger than a diameter of the implantation site such that delivery and expansion of stent component 300 at the implantation site secures stent component 300 in place by way of a friction fitting. In some embodiments, stent component 300 may include one or more projections (e.g., spikes) or clasps for anchoring stent component 300 to the failed valve and/or adjacent structure(s) at the implantation site.

FIGS. 5A-7B illustrate embodiments of the present invention for replacing a failed artificial (e.g., biological) valve (e.g., stent-valve) introduced to a patient's body during a prior surgery. FIG. 5A is a perspective view of a failed biological valve 500 where leaflets 502 of the valve fail to close. FIG. 5B is a perspective view of the failed biological valve 500 after implantation of the stent-valve shown in FIG. 2B. As shown, failed biological valve 500 (e.g., and/or its accompanying stent) secure the new stent-valve in place at the implantation site. More particularly, fixation element 202 of the stent-valve (FIGS. 2A and 2B), which may be an annular groove forming the narrowest portion of the stent-valve, may receive the annulus of failed biological valve 500 thereby securing the stent-valve in place. In other embodiments of the present invention, at least a portion of failed biological valve 500 may be removed from the patient's body (e.g., the failed valve itself), whereas other portion(s) of the failed valve may be left behind at the implantation site (e.g., a supporting stent). In still other embodiments, the failed biological valve 500 including all of its associated component(s) may be substantially entirely removed from the implantation site prior to installation of the new stent-valve.

FIG. 6A is a perspective view of another example of a stent-valve 600 in accordance with an embodiment of the present invention. FIG. 6B is a perspective view showing a use of stent-valve 600 to replace a failed artificial (e.g., biological) valve. Stent-valve 600 includes one or more (e.g., three) locking or retaining elements 602 along an outer surface of the stent component. Each locking element 602 may include directionality such that it collapses (e.g., becomes flush with an outer surface of the stent component) upon engagement of the locking element with another surface (e.g., the interior of a catheter). When a locking element 602 protrudes from the outer surface of the stent component, a first end 604 of the locking element may be adjacent to the outer surface of the stent component, while a second end 606 of the locking component may be spaced apart from the outer surface of the stent component. When multiple locking elements 602 are provided, first ends 604 of all the locking elements may be positioned at substantially the same vertical height/position along the central axis of the stent component (e.g., albeit dispersed evenly around the perimeter of the stent component), and second ends 606 may be positioned at different vertical height(s)/position(s) than first ends 604. First end 604 may be flexible (e.g., allowing hinge-like movement in two dimensions) such that movement of the second end relative to the outer surface of the stent component does not impair the locking mechanism.

In some embodiments of the present invention, stent-valve 600 may be inserted into the interior of the failed valve in the direction of arrow 608 in FIG. 6B. When first end 604 of each locking element 602 encounters the interior diameter/annulus of the failed valve, second end 606 of the locking element may collapse toward the outer surface of the stent component. Upon second end 606 of the locking element reaching an open area of the failed valve, the second end may jut outwardly, locking stent-valve 600 in place. Thus, locking elements 602 may provide a mechanism for securing the new stent-valve in place, as an alternative to or in addition to fixation element 610 (e.g., annular groove) of the stent component for affixing stent-valve 600 to (for example) the annulus the failed valve.

FIGS. 7A and 7B show another embodiment of a stent component 700 with locking elements in accordance with the present invention. FIG. 7A shows that such a stent component can be made from, for example, a sheet of suitable material (e.g., nitinol). Referring to FIG. 7B, stent component 700 includes one or more locking elements 702 that extend radially from an outer surface of the stent component such that, for each locking element, first end 704 and second end 706 of that locking element have substantially the same vertical position/height along the central axis of the stent component. In other embodiments, such locking elements may be slightly angled, such that ends 704 and 706 of the same locking element have different relative vertical positions/heights along the central axis of the stent component. In some embodiments, a stent component may be provided that includes multiple locking elements, with each locking element having ends 704 and 706 with different angular orientations. Different locking elements 702 may have the same or different vertical positions/heights along the central axis of the stent component.

FIGS. 8A-16 show additional examples of suitable stent components for use in valve replacement in accordance with some embodiments of the present invention. These stent components may be used, for example, as part of single-stent-valves and double-stent-valves. Each of these stent components includes one or more attachment elements for removably attaching the stent component (e.g., together with an integrated valve component) to a delivery device (FIGS. 22-26). In some embodiments, these stent components may also include a fixation element (e.g., similar to fixation element 202 (FIG. 2A)) for fixing the stent component in place at the implantation site.

FIG. 8A shows a perspective view of a stent component 800 in a collapsed configuration, as well as an as-cut view of stent component 800 that illustrates details regarding its structure. FIG. 8B shows stent component 800 in an expanded configuration. Stent component 800 includes first (e.g., proximal) section 802 that includes a fixation element (e.g., annular groove), second section 804 that may follow the contour of a valve component to be housed therein, and third (e.g., distal) section 806 that includes one or more (e.g., three) attachment elements 808. In some embodiments, stent component 800 may include (for example) a lattice structure (e.g., formed from nitinol wire), for example, with section 802 having a denser population of lattice cells than section 804 and/or section 806. This may provide added support to the fixation element in section 802 and therefore increase the stability of device 800 at the implantation site. In some embodiments, stent component 800 may include only closed lattice cells in order to facilitate the recapture of stent component 800 by a delivery device when stent component 800 is in a partially-expanded configuration (described below).

In some embodiments, each of attachment elements 808 may include an opening (e.g., circular or ovular) for removably attaching stent component 800 to a complimentary element (e.g., wire, strap or hook) of a delivery device. Attachment elements 808 may allow for partial expansion of the stent component (e.g., together with an integrated valve component and/or another stent component) within a patient's body while causing the stent component to remain attached to the delivery system. For example, sections 802 and 804 (e.g., and part of section 806) of stent component 800 may expand when stent component 800 is partially released from a shaft during delivery, whereas no change may be observed to the relative positions of attachment elements 808 still constrained by the shaft (e.g., see FIG. 27 “partial release”). This may allow a surgeon to reposition and/or test the functionality of the stent-valve (or double-stent-valve) within the patient's body before finalizing deployment of the stent-valve at the implantation site. Such testing of the valve functionality may include peripheral pulse monitoring, whereby a pulse wave is measurable if the valve is functioning properly. A more reliable assessment of the stent valve function can be made with transesophageal echocardiography (TEE), intravascular ultrasound (IVUS) and/or intracardiac echocardiography (ICE). If the stent-valve malfunctions during the test (e.g., if the valve does not permit sufficient blood-flow), the stent-valve may be fully recaptured by the delivery device and retrieved from the patient's body. In other embodiments, stent component 800 may have a different lattice structure, attachment elements 808 may be reduced or enlarged in length and/or other dimension(s), and/or attachment elements 808 may be included in other location(s) relative to stent component 800 (e.g., within section 804).

FIG. 8C shows another embodiment of a stent component with integrated attachment elements 814 that are configured such that the fully expanded diameter in the region of the attachment element(s) is smaller than the diameter of the region that houses an associated valve. As shown in this example, the attachment elements project partially inwardly toward the center axis of the stent component. This may reduce the risk of injury to the patient's body (e.g., perforation of the aorta) from the attachment elements. Alternatively or additionally, this may make it easier to affix the attachment elements to a complimentary structure of the delivery device. For example, when the device is collapsed for attachment to the delivery device, the reduced diameter within the region of the attachment elements may cause the attachment elements to engage the stent holder earlier.

FIG. 8D shows yet another embodiment of a stent component in accordance with the present invention. In this embodiment, the first (proximal) section of the stent includes 27 independent, bendable elements 816, each of which may include connected and/or disconnected cell(s) which can be open and/or closed. In this embodiment, each bendable element includes a single, closed cell. In other embodiments, other number(s) and/or configuration(s) of the bendable elements may be provided. Bendable elements 816 allow for accurate positioning/securing of the proximal stent section to the geometry/topology of (for example) a calcified annulus/failed biological valve. Each element 816 can bend/adapt independently to the topology of the immediately adjacent portion of the calcified annulus/failed biological valve. Bendable elements 816 collectively form an annular groove in which the location of the bending deformation (grooved portion) for each bendable element is controlled by reducing or elongating the lengths of an attached pair of stent struts (818, 820) which act as a joint. The length of a single stent strut is shown by numeral 822. Primarily, the radial force/resistance of each bendable element 816 is influenced by the selection of angle 824 during stent manufacturing. Other design parameters such as strut thickness/width also influence the radial force. An advantage of this design is that the stent proximal section can more adequately anchor the stent in place at the implantation site independently of the stent mid section. Thus, the stent mid section can be designed to accommodate (for example) the aortic valve without any over sizing, therefore reducing the risk of valve failure due to long term mechanical stress. The stent of FIG. 8D also includes compensation element 826 (e.g., including a triangular wave portion and two elongate arms) for accommodating elongation mismatch (if any) within the stent during manufacturing and/or crimping. Contrast FIG. 8D with the embodiment shown in FIG. 8C, in which the absence of dedicated pairs of struts prevents the stent proximal section from having elements that bend independently (e.g., during implantation).

FIG. 8E shows another embodiment of a stent component in accordance with the present invention. In FIG. 8E, only about ⅓ of an as-cut view of the stent component is shown in order to more clearly show its features. Similar to the locking/retaining elements 602 shown in FIGS. 6A and 6B, the stent component shown in FIG. 8E includes a plurality of independently bendable locking elements 828 generally located within the region of the stent component referenced as region 804 in FIG. 8B. Locking elements 828 form a crown that may engage, for example, a failed biological valve or calcified native annulus from the outflow side. The stent component in FIG. 8E also includes fixation element 830 (e.g., annular groove). In FIG. 8E, locking elements 828 are shown as being positioned at substantially the same position/height along the central axis of the stent component. In other embodiments, different locking elements 828 may have the same or different vertical positions/heights along the central axis of the stent component similar to, for example, the stent shown in FIG. 7B. Having different positions/heights for at least some of locking elements 828 may facilitate engagement with, for example, native valves of different sizes (e.g., a thin native valve which can be engaged by locking elements separated by a small distance or a thick native valve which can only be engaged by more distantly spaced locking elements).

FIG. 8F shows another embodiment of a stent component in accordance with the present invention. In FIG. 8F, only about ⅓ of an as-cut view of the stent component is shown in order to more clearly show its features. FIG. 8F includes a Dacron pocket 832 for housing a valve component, where Dacron pocket 832 is sutured along the valve free edge 834. As shown, the valve component within pocket 832 is housed more closely to attachment element(s) 836, which are similar to attachment elements 808 in FIG. 8B, in the embodiment of FIG. 8F than in the embodiment shown in FIG. 9C. A middle inverted U-shaped strut 838 is slid into Dacron pocket 832. The valve/pocket is sutured to an outer inverted U-shaped strut 840. Inner U-shaped strut 842 is positioned outside Dacron pocket 832 and serves as a skid during loading/releasing/recapturing of the implant with a delivery device by reducing the friction forces between Dacron pocket 832 and the outer sheath. Inner U-shaped strut 842 may also be sutured to Dacron pocket 832. In some embodiments, Dacron pocket 832 may be closed with further stitching 844. Although the bottom portion of the stent is not shown in FIG. 8F, in some embodiments it may include, for example, a fixation element (e.g., annular groove) similar to fixation element 802 in FIG. 8B.

FIGS. 9A-9C show another example of a stent component 900 with integrated attachment element(s) 902 in accordance with an embodiment of the present invention. FIG. 9A shows a perspective view of stent component 900 in a collapsed configuration, as well as an as-cut view of stent component 900 that illustrates details regarding its structure. FIG. 9B is a perspective view of stent component 900 in an expanded configuration. FIG. 9C shows stent component 900 (with an integrated valve component) positioned beside a ruler to show its size (e.g., about 4 centimeters). As shown, each of attachment elements 902 includes a circular or ovular opening attached to stent component 900 by two supporting elements 904 (e.g., wires). In turn, each pair of supporting elements 904 attaches to a stem 906 (e.g., commissural post) within the lattice structure. In contrast, each of the attachment elements 808 in FIG. 8B attaches to stent component 800 by a single supporting element 810, and each supporting element 810 is attached to a stem 812. All of the stent components shown in FIGS. 8A-16 include three stems, although it will be understood that other suitable numbers of stems or no stems at all (e.g., FIG. 2A) may be provided in accordance with some embodiments of the present invention. Stent component 900 also includes a fixation element 908, which may be substantially similar to fixation element 202 (FIG. 2A). In the embodiment of FIG. 9C, the valve component is sutured around the circumference of its annulus. Each of the three leaflets of the valve component is also spot-sutured to the stent to permit valve functionality. The locations of the sutures may be selected in order to permit elongation of the stent during crimping without damaging the valve or suture. For example, the inflow of stent (e.g., within region 802 shown in FIG. 8B) may be covered on its inner side with a cloth (e.g., mesh). The cloth and valve component may be sutured to the stent (e.g., using a running and/or interrupted technique) in the region adjacent to the annular groove (e.g., along the border of stent sections 802 and 804 in FIG. 8B). Some excess cloth on the inflow side may be folded over onto the exterior side of the stent and sutured together with the valve component in the vicinity of (e.g., further towards section 804) the previous suturing location. The commissures of the valve component may also be attached to the corresponding stent posts, which may have previously been covered with cloth (e.g., Dacron). Alternatively, pericardium or other suitable material can be used to cover the stent component. In some embodiments, the valve component may be a porcine valve component which may be harvested as such or assembled from various donors in order to have an optimal match between three cusps. Bovine and equine valves may also be used that are made from pericardium. Other suitable sources of valve components can also be used.

FIGS. 10A-10B show yet another example of a stent component 1000 with integrated attachment element(s) 1002 in accordance with an embodiment of the present invention. FIG. 10A shows a perspective view of stent component 1000 in a collapsed configuration, as well as an as-cut view of stent component 1000 that illustrates details regarding its structure. FIG. 10B is a perspective view of stent component 1000 in an expanded configuration. As shown, at least one pair (e.g., all pairs) of attachment elements 1002 are attached to one another with a bracing element 1004. Each bracing element 1004 may attach on one end to a first attachment element 1002 and on the other end to a second attachment element 1002. In some embodiments, the bracing element(s) 1004 may include a wire shaped like a triangular wave. When all attachment elements 1002 include a bracing element 1004, collectively the bracing elements 1004 may form a circle around the perimeter of stent component 1000. Stent component 1000 may be substantially the same as stent component 800 (FIG. 8B) in all other respects.

FIGS. 11-16 show additional examples of stent components with integrated attachment element(s) in accordance with some embodiments of the present invention. Each of FIGS. 11-16 includes a perspective view of a stent component in a collapsed configuration, as well as an as-cut view of the stent component that illustrates details regarding its structure. The following description summarizes various features of the stent components shown in FIGS. 11-16. Additional structural features of the embodiments shown in FIGS. 8A-16 will be apparent to one of ordinary skill in the art from the drawings.

FIG. 11 shows a stent component that includes shorter supporting element(s) for attaching to a corresponding number of ovular/circular attachment element(s) (i.e., shorter in comparison to supporting elements 810 of FIG. 8B). The stem(s) in FIG. 11 for attaching to the supporting elements may be substantially the same as stems 906 in FIG. 9B.

FIG. 12 shows a stent component that includes two supporting elements for attaching to each ovular/circular attachment element. Each pair of supporting elements attaches to a stem such that collectively the supporting elements and stem form a second ovular/circular opening, for example, for added support and/or for use as an additional or alternative attachment element. The stem(s) in FIG. 12 may be substantially the same as stems 906 in FIG. 9B.

FIG. 13 shows a stent component that includes non-circular/ovular attachment components such as, for example, wires, hooks, straps, or a combination thereof for matably attaching to a complimentary element of a delivery device (e.g., a circular or ovular opening). The stent component in FIG. 13 also includes an increased number of attachment elements (e.g., six) when compared to the number of attachment elements (e.g., three) of stent component 900 (FIGS. 9A and 9B). In FIG. 13, the attachment elements attach directly to the stems of the stent component, two attachment elements per stem. The stem(s) in FIG. 13 may be substantially the same as stems 906 in FIG. 9B.

FIG. 14 shows a stent component that replaces the wire/hook attachment elements in FIG. 13 with long, narrow openings (e.g., long and narrow in comparison to attachment elements 902 of FIG. 9A). The stem(s) in FIG. 14 may be substantially the same as stems 906 in FIG. 9B.

FIG. 15 shows a stent component with a modified lattice structure, including a modified stem structure. The stent component in FIG. 15 also includes circular/ovular attachment elements, where each attachment element is attached to a stem by two supporting elements. Each pair of supporting elements and corresponding stem may form a second circular/ovular opening, in a manner similar to the supporting element/stem configuration shown in FIG. 12.

FIG. 16 shows a stent component with attachment elements modified relative to the attachment elements shown in FIG. 15. Each attachment element in FIG. 16 includes a wire (e.g., a “U”-shaped wire), with both ends of the wire attaching directly to the same stem such that the attachment element/stem configuration forms a substantially ovular/circular opening. The stem(s) in FIG. 16 may be substantially the same as the stems shown in FIG. 15.

FIGS. 17/18, 19 and 20 show additional examples of double-stent-valves in accordance with some embodiments of the present invention. Single-stent valve 1700 of FIG. 17 includes stent 1702 and valve component 1704. FIG. 18 shows a double-stent valve that includes stent-valve 1700 and positioning stent 1802, which may be attached together by way of (for example) an annular groove and corresponding annular recess. Stent component 1802 may be covered with, for example, pericardium in order to prevent paravalvular leaking. The double-stent-valve of FIG. 18 may have a generally cylindrical shape that is suitable for, for example, pulmonary and/or aortic applications.

Now referring to FIGS. 19 and 20, FIG. 19 shows a double-stent-valve with first stent 1902, second stent 1904, and valve component 1906. FIG. 20 shows a double-stent-valve with first stent 2002, second stent 2004, and valve component 2006. Again, the positioning stents in FIGS. 19 and 20 may be covered (e.g., with pericardium) in order to prevent perivalvular leaking. The stents of FIGS. 19 and 20 may be suitable for, for example, pulmonary valve replacement (e.g., in the presence of an aneurysm that creates a deformation and where there is no suitable rim for placement of a grooved stent-valve). More particularly, with respect to pulmonary valve applications, many candidates for pulmonary valve replacement have an aneurysm there or a funnel-type configuration at the inflow or at the outflow. Thus, the first stent 1902 or 2002 can adapt to this funnel-type pulmonary artery configuration and provide the round orifice for securing the stent-valve (1904, 1906) or (2004, 2006). In some embodiments, a double-stent-valve similar to the double-stent-valve of FIG. 20 may be provided that is suitable for mitral and/or tricuspid valve applications, where the positioning stent has a reduced height and an oval configuration that provides a round rim for attachment to a groove of a stent-valve (alternatively, a hook-loop fastening system can be used). Alternatively or additionally, the positioning stent may have independently bendable elements that provide a secure fit at the implantation site. Additional structural features of the embodiments shown in FIGS. 17-20 and details regarding their use for valve replacement will be apparent to one of ordinary skill in the art from the drawings.

FIG. 21A shows another example of a stent-valve 2100 in accordance with some embodiments of the present invention. The embodiment shown in FIG. 21A may be suitable for, for example, mitral valve replacement. Stent-valve 2100 may be assembled from a stent component and a valve component outside the patient's body prior to delivery of stent-valve 2100 to an implantation site. Stent-valve 2100 may be a self-expanding stent-valve adapted for replacement of the mitral valve. As shown, stent-valve 2100 may have a shape similar to an opposed double crown. Stent-valve 2100 may include a porcine pulmonary valve 2102 sutured into a Dacron conduit (prosthetic tube), with two self-expanding nitinol Z-stents 2104 and 2106 sutured on the external surface of the prosthesis in such a way to create two self-expanding crowns. The self-expanding stent-valve may be loaded for delivery into a Teflon sheath, or other suitable delivery system. In this embodiment, Dacron is used to cover the stent, although in other embodiments other materials such as Teflon, silicon, pericardium, etc. may be used. In one surgical approach, an incision of 1 centimeter may be made on the left atrium, controlled by purse string sutures. The Teflon sheath with loaded stent may be pushed along a guide wire (the atrium having been punctured with a needle and the guide wire inserted) until the middle of stent-valve reaches the mitral annulus. Then, the sheath may be pulled back to deploy the ventricular side first, followed by total removal of the sheath to expose the atrial side. Additional details regarding stent-valve 2100 and a surgical approach for delivering it to an implantation site are described in Liang Ma et al., “Double-crowned valved stents for off-pump mitral valve replacement”, European Journal of Cardio-Thoracic Surgery 28:194-199, Jun. 13, 2005, which is incorporated by reference herein in its entirety.

FIGS. 21B-E show views of a double-conical stent in accordance with some embodiments of the present invention. Referring to FIGS. 21B and 21C, the double-conical stent may include a substantially cylindrical stent 2108 carrying a valve 2110 as well as two substantially conical stents (2112, 2114) affixed/attached to stent 2108 (e.g., with VELCRO®, suture(s), friction fitting(s), other suitable affixing mechanism(s), or a combination thereof). FIG. 21D shows a cross-section of the double-conical stent shown in FIGS. 21B and 21C. In other embodiments, at least one of stents 2112 and 2114 may have a crown-shape with protruding spikes formed from open or closed cells or Z-stents. The first and second additional stents (2112, 2114) may collectively form a fixation element 2116 (FIG. 21C; e.g., annular groove) similar to fixation element 202 shown in FIG. 2A. Fixation element 2116 may allow for fixation, for example, in an orifice of a failed valve which is of similar size as the stent 2108 carrying valve component 2110 or to an anchoring stent with a complimentary annular projection. In some embodiments, stents 2112 and 2114 (and optionally stent 2108) may be replaced with a single stent in a double-conical configuration (e.g., the two cones connected by a continuous region in the area of fixation element 2116). An advantage to using separate stent(s) for the cones/fixation element is that the mechanical stresses of the cones/fixation element (e.g., first and second stents 2112 and 2114) can be at least partially separated from stent 2108 containing the valve. In some embodiments, at least the additional stent or portion thereof positioned closer to the tip of the delivery system (e.g., stent 2112) may be recapturable by the delivery system. To facilitate such recapturing, the additional stent may be formed in a pyramid or wing cross-sectional configuration 2118 (FIG. 21E). In some embodiments, the wing(s) or spikes of stent 2112 (and/or 2114) may be formed at various positions/heights along a central axis of stent 2108 similar to, for example, the stent shown in FIG. 7B. Having different positions/heights for at least some of the wings or spikes may facilitate engagement with, for example, native valves of different sizes. In some embodiments, the stents shown in FIGS. 21B-21E (e.g., stent 2108) may include at least one attachment element for removably attaching to a delivery device, similar to attachment elements 808 shown in FIG. 8B.

FIGS. 22A-26C show examples of delivery systems for delivering stent-valves (e.g., single-stent-valves or double-stent-valves) to an implantation site in accordance with some embodiments of the present invention. In some embodiments, the present invention provides a minimally-invasive surgical approach whereby the surgery is performed on a beating heart without the need for an open-chest cavity and heart-lung bypass. The heart may be penetrated, for example, trans-apically through a relatively small opening in the patient's body. For example, to replace a failed aortic valve, the patient's body may be penetrated through an intercostal space (e.g., fifth intercostal space), which is a region between two ribs. From this access point, the left ventricle may be penetrated at the apex of the heart. In one approach, a suitable stent-valve delivery system may initially penetrate the body/heart (e.g., delivery system 2600 (FIGS. 25A-26C) which includes an integrated introducer). In another approach, a separate introducer sheath may be used. A guide wire (hollow needle, catheter, stiff guide wire, etc.) may be inserted through the introducer to guide delivery of, for example, stent component(s), a valve component, and/or other devices (e.g., an occluder device). In some embodiments, transluminal, transatrial, or transventricular access approaches may be used for, for example, tricuspid and/or mitral valve replacement. The right ventricle of the heart may also be accessed for pulmonary valve replacement. This is in contrast to other surgical approaches that deliver replacement valves via open-chest cavities. Moreover, as described in greater detail below in connection with FIGS. 22A-28C, delivery systems according to some embodiments of the present invention release the proximal portion of the stent-valve first, which may allow for testing of the valve when the body is accessed, for example, trans-parietally. Upon a successful test, the distal portion of the stent-valve may be released. This contrasts with stent delivery systems that initially release the distal portions of their associated stents.

FIGS. 22A-22D show a delivery system 2200 that includes two concentrically-arranged parts, a first assembly (including elements 2202-2210) and a second assembly (including elements 2216-2230). More particularly, the first assembly may include tip 2202 at the distal end of the delivery system (with a guide wire passing through the length of the delivery system and out the tip), inner shaft 2204, outer sheath 2206, metal shaft 2208, and push handle 2210. The second assembly may include outer shaft (distal) 2216, tapered outer shaft connector 2218, outer shaft (proximal) 2220, stent holder 2222, kink protector 2224, hold handle connector 2226, hold handle cup 2228, and O-ring 2230. As shown, push handle 2210 is located at the proximal end of the delivery system. In FIGS. 22A and 22B, outer shaft 2220 has been split along its length to allow the components of delivery system 2200 to be shown in greater detail. Valve 2212 and stent(s) 2214 form a third assembly that can be, for example, loaded and crimped between the first and second assemblies.

With respect to the first assembly, inner shaft 2204 functions as a lumen for a guide wire. Tip 2202 is bonded at its distal end. As used herein, bonding refers to any suitable securing/fastening mechanism such as, for example, adhesive bonding using cyanoacrylate or UV-curing adhesives or thermal bonding/welding using heat energy to melt the components to be assembled. Outer sheath 2206 may be bonded to the proximal section of tip 2202 and may constrain the stent-valve (2212, 2214). Outer sheath 2206 may be perforated to allow device flushing via hold handle 2210. The proximal part of the first assembly may be reinforced with metal shaft 2208 and may end into the push handle with a luer connector for guide wire lumen flushing.

With respect to the second assembly, stent holder 2222 may be bonded distally on distal outer shaft 2216. FIG. 22D shows a perspective view better illustrating the arrangement between the stent-valve (2212, 2214) and stent holder 2222. Distal outer shaft 2216 may be bonded proximally to proximal outer shaft 2220 via tapered connector 2218. Proximal outer shaft 2220 may be bonded via kink protector 2224 to the hold handle assembly, which may include hold handle connector 2226 and hold handle cup 2228. The hold handle assembly may compress O-ring 2230 for sealing delivery system 2200. A luer connector may allow for device flushing. The flush mechanism may be used to remove trapped air from the delivery system prior to its insertion into the body. Alternatively or additionally, the flush mechanism may be used to cool down a stent (e.g., nitinol stent) prior to its release and/or recapture by flushing the stent with a cold saline solution. Cooling down the stent may cause a reversible modification of its structure, thus reducing its Young-modulus and therefore the stent radial force and the forces necessary for its delivery and recapture.

Delivery system 2200 is said to be in an open position (FIG. 22C) when (for example) push handle 2210 contacts the hold handle cup 2228. In the open position, the stent-valve (2212, 2214) may detach from stent holder 2222 and fully expand at an implantation site. Prior to delivery system 2200 reaching the open position, the stent-valve may be crimped onto delivery system 2200 by means of a crimping machine (for example) and held in place by stent holder 2222. Stent holder 2222 may affix to the attachment elements of the stents shown in FIGS. 8A-16. The crimped stent-valve may be maintained in a collapsed configuration by pulling back the first assembly thus covering the attachment components/stent holder 2222 with outer sheath 2206. Once the outer sheath 2206 is removed such that it no longer constrains the attachment components, the stent-valve may automatically detach from stent holder 2222 due to the self-expanding property of the stent-valve. Delivery system 2200 is said to be in a closed position (FIGS. 22A and 22B) when outer sheath 2206 fully encompasses the stent-valve (2212, 2214) such that no expansion of the stent-valve occurs.

Delivery system 2200 is said to be in a partially open position when (for example) push handle 2210 is partially pushed towards hold handle cup 2228. In this partially open position, the stent-valve (2212, 2214) is deployed proximally and still attached distally to stent holder 2222 via the attachment elements. This allows for an accurate implantation/positioning of the stent-valve. For example, the stent-valve may be partially released proximal to the intended implantation site and slightly pushed distally until resistance is felt. Final release of the stent-valve (2212, 2214) may occur by completely pushing the push handle towards hold handle cup 2228 so that delivery system 2200 reaches the open position. Such a partially-open position is illustrated in FIG. 27B. In some embodiments, an imaging mechanism may be used to determine whether the stent-valve is positioned correctly at the implantation site. For example, roadmapping under fluoroscopy can be realized with angiography, intra-vascular ultrasound (IVUS), intra-cardiac echocardiography (ICE), trans-esophageal echocardiography (TEE) or other mechanism(s) or combination thereof, which imaging mechanism may be at least partially integral to or separate from the delivery system.

Upon implantation of the stent-valve (2212, 2214), delivery system 2200 may revert to the closed position prior to retrieval from the patient's body, for example, by holding the first assembly and pushing the second assembly distally towards tip 2202/outer sheath 2206. In other embodiments, the handle for releasing the stent-valve may comprise a screw mechanism for transferring a rotational movement of the handle into a translational movement of the outer sheath. This type of release system may allow for stepwise, more accurate stent release and recapturing as well as a reduction of the release force felt by the surgeon.

FIGS. 23A-23D show another example of a delivery system 2300 in accordance with an embodiment of the present invention. Delivery system 2300 may be substantially similar to delivery system 2200 (FIG. 22) (e.g., closed position, FIGS. 23A and 23B; opened position, FIG. 23C), except delivery system 2300 may additionally include one or more folded balloons 2302 (e.g., proximal to the stent-valve). Unless otherwise indicated, like features in FIGS. 23A-23D correspond to the same reference numerals in FIGS. 22A-22D, although the reference numerals have not been reproduced in FIGS. 23A-23D to avoid overcomplicating the drawings. The same applies to the stent delivery systems shown in FIGS. 24A-24D, FIGS. 25A-C, and FIGS. 27A-C. Balloon 2302 may be inflated/deflated via an additional lumen in proximal outer shaft 2304, for example, to anchor the stent-valve (e.g., a non-self-expanding stent-valve) in place at an implantation site. FIG. 23D shows a cross section “A-A” of the lumen structure shown in FIG. 23C. The lumen structure includes 5-lumen tubing 2306 and inner shaft 2308. In other embodiments, other structures for lumen tubing 2306 may be used (e.g., bi-lumen tubing where the second lumen is used for balloon inflation and deflation). Delivery system 2300 may also include access mechanism 2310 for balloon inflation/deflation, which may allow connection of a syringe or inflation device to inflate/deflate a balloon. Alternatively or additionally, tubing with an attached stop-cock may be connected to access mechanism 2310.

FIGS. 24A-24D show another example of a delivery system 2400 in accordance with an embodiment of the present invention. In delivery system 2400, proximal outer shaft 2402 may have an increased diameter in comparison to the diameter of proximal outer shaft 2220 (FIG. 22). The increased diameter may reduce bleeding when the delivery system is used without an introducer. Alternatively, when an introducer is used, the increased diameter may match the internal diameter of the introducer which, in turn, may depend on the outer diameter of the outer sheath. Having no gap between the introducer and delivery system may reduce the risk of a potential retrieval issue of the delivery system through the introducer due to entrapped blood. Accordingly, delivery system 2400 may include a floating tube 2404 that fills the gap between the inner and outer assemblies, thus reducing the risk of the inner assembly kinking under compression which would result in higher friction forces within the delivery system during stent recapturing. Delivery system 2400 may be substantially similar to delivery system 2200 in all other respects (e.g., closed position, FIGS. 24A and 24B; opened position, FIG. 24C).

FIGS. 25A-C show another example of a delivery system 2500 in accordance with an embodiment of the present invention. Delivery system 2500 may include one or more balloons 2536 distal to the stent-valve. Having the balloon(s) distal to the stent-valve avoids having to introduce the delivery system deeper into the body (e.g., into the ascending aorta) in order to perform dilation, thereby reducing risk of injury to the body and improving device handling (e.g., no bending of rigid device over the aortic arch). Balloon(s) 2536 can be used for, for example, valvuloplasty prior to stent-valve implantation and/or post-dilation of the implanted stent-valve to improve the anchoring of the stent. FIGS. 25B and 25C show the balloon(s) 2536 in closed and open positions, respectively.

The first assembly of delivery system 2500 may include tip 2502, inner balloon shaft 2504, outer sheath 2506, and floating tube 2208. The second assembly may include inner shaft (distal) 2510, stent holder transition 2512, stent holder 2514, sleeve 2516, tapered transition shaft connector 2518, and outer shaft (proximal) 2520. The handle assembly may include hold handle connector 2522, hold handle cup 2524, O-ring 2526, metal shaft 2528, and push handle 2530. The balloon assembly may include outer shaft 2532, inner shaft 2534, balloon 2536, and Y connector 2538.

FIGS. 26A-C show another example of a delivery system 2600 in accordance with an embodiment of the present invention. Delivery system 2600 may include an integrated introducer 2602, which may be an additional assembly that houses the second assembly. The outer sheath of the delivery system is shown as 2604. Introducer 2602 may include a connecting line 2606, a stopcock 2608 and a housing 2610 for the sealing membrane 2612. Stopcock 2608 may serve as an access point for, for example, a syringe containing fluid (e.g., saline). Connecting line 2606 may serve to transport the fluid from the syringe to the inner lumen of the introducer, and sealing membrane 2612 may seal the introducer from the outside environment. Upon stent-valve implantation, the components of delivery system 2600 (e.g., first assembly and second assembly) other than introducer 2602 may be retrieved through the introducer. Then, another medical device such as, for example, a closure device may be introduced through introducer 2602. Examples of closure devices are described below in connection with FIGS. 29A-33B. As another example, intravascular ultrasound (IVUS) equipment (e.g., mini-probe) may be introduced through introducer 2602. Delivery system 2600 may be substantially similar to delivery system 2200 in all other respects.

FIG. 27 is a flowchart 2700 of illustrative stages involved in replacing a failed (e.g., native or artificial) valve in accordance with some embodiments of the present invention. FIGS. 28A-28C illustrate (without limitation) various stages referenced in the flowchart of FIG. 27. At stage 2702, a stent-valve (e.g., single-stent-valve or double-stent-valve) may be removably attached to a delivery system. For example, one or more attachment elements of a stent component (e.g., attachment elements 808, FIG. 8B) may be affixed to a stent holder of the delivery device (e.g., stent holder 2222, FIG. 22). A collapsing element (e.g., outer sheath 2206, FIG. 22) may be placed over the attachment elements/stent holder to maintain the stent-valve in a collapsed configuration and attached to the delivery system.

At stage 2704, the stent-valve may be delivered to an implantation site in a collapsed configuration. For example, FIG. 28A (“introduction” and “positioning”) shows that stent-valve 2802, while still attached to the delivery system via stent holder 2804 and fully contained within outer sheath 2806, may be introduced to a patient's body along guide wire 2808 so that tip 2810 of the delivery system passes through failed valve 2812. The delivery system may be manipulated forwards and/or backwards, for example, until the stent-valve is believed to be positioned correctly.

At stage 2706, the stent-valve may be partially expanded, for example, to determine (stage 2708) whether the stent-valve is in fact positioned correctly and/or to test (stage 2710) whether the stent-valve is functioning properly. For example, FIG. 28A (“partial release”) shows that outer sheath 2806 may be partially removed from proximal section 2814 of the stent-valve, while attachment elements 2816 of the stent-valve are still constrained by outer sheath 2806 onto stent holder 2804.

At stage 2712, when the stent-valve is positioned correctly at the implantation site and/or the stent-valve is functioning properly, the stent-valve may be detached from the delivery system in order to cause the stent-valve to expand to its fully-expanded configuration. For example, FIG. 28C (“final release”) shows that, upon removal of attachment elements 2816 and stent holder 2804 from within outer sheath 2806, attachment elements 2816 of stent-valve 2802 may detach from stent holder 2804 automatically (or in response to balloon inflation in other embodiments) thereby causing the stent-valve to expand to its fully-expanded configuration. The second assembly of the delivery device may then be reunited with the first assembly/outer sheath and removed from the patient's body. For example, FIG. 28C (“delivery device retrieval”) shows that the second assembly 2818 may be passed through replacement stent-valve 2802 towards the distal end of the stent-valve. Then, the reunited second assembly 2818 and first assembly/outer sheath 2806 may be passed through stent-valve 2802 again in the proximal direction before exiting the patient's body.

When the stent-valve is not positioned correctly (stage 2708), at stage 2714 the stent-valve may be reverted to the collapsed configuration and repositioned within the patient's body. An illustration of this scenario is illustrated in FIG. 28B (“stent recapturing/repositioning”), in which outer sheath 2806 is slid in the proximal direction over proximal section 2814 of the stent-valve in order to recapture the stent-valve. The stent-valve is then repositioned and released such that fixation element 2820 of the stent-valve receives an annulus 2822 of the failed valve. Similarly, when the stent-valve malfunctions in response to a test (stage 2710), at stage 2716 the stent-valve may be reverted to the collapsed configuration and removed from the patient's body.

FIGS. 29A-33B show illustrative embodiments of guide wire compatible closure (occluder) devices for sealing access orifices and associated surgical instruments in accordance with some embodiments of the present invention. Such an occluder may repair, for example, a cardiac access orifice (e.g., ventricular orifice) used for valve replacement. The occluder may be introduced to a patient's body after a replacement valve has been implanted (or removed due to malfunction or complication during installation). Embodiments of the present invention address shortcomings with conventional closure devices, such as the looseness of their fit. Conventional closure devices also lack a central lumen, which renders them incompatible with guide wire delivery systems.

FIGS. 29A and 29B are side and perspective views of an occluder 2900 in accordance with some embodiments of the present invention. Occluder 2900 may include stainless steel wire, nitinol, textile fibers, fills, biocompatible materials, and/or other suitable materials which allow the device to perform as intended. In some embodiments, at least a portion of occluder 2900 may be fitted/filled with a flexible but tight material such as, for example, a membrane or foam. Occluder 2900 may or may not include a skeleton (e.g., lattice structure with a filling material) and/or sealing membranes. Such a skeleton may comprise nitinol, stainless steel, magnesium, nylon, polyester, polypropylene, polydioxanon, other suitable material(s), or a combination thereof. The filling material may include, for example, polyester, polyurethane, gelatine, other suitable material(s), or a combination thereof. When occluder 2900 includes a sealing mechanism, such a mechanism may be flexible such that it does not interfere with the expanding or collapsing of occluder 2900 (described below) according to some embodiments of the present invention.

Top portion 2902 of occluder 2900 may be positioned on the luminal side of an access orifice, while bottom portion 2904 may be positioned outside the access orifice. Guide wire compatibility may be achieved through a central channel within occluder 2900. The central channel may include at its bottom end, for example, a hollow screw device 2906 for attaching occluder 2900 to a catheter during delivery and detaching the occluder from the catheter upon installation within the access orifice. In other embodiments, occluder 2900 may be attached/detached to a catheter by a thin wall that can be twisted off, by a connection mechanism in the shape of a hook, or by a mechanism that detaches via galvanic corrosion or the like.

Occluder 2900 may include a channel sealing mechanism 2908 such as, for example, a self-sealing membrane and/or foam. In some embodiments, channel sealing mechanism 2908 may include a valve (e.g., one or more plastic leaflets). Channel sealing mechanism 2908 may prevent blood-flow through the occluder from top/luminal portion 2902 to bottom portion 2904 after the occluder is installed within the access orifice. During delivery, the positioning of a guide wire through channel sealing mechanism 2908 (and the central channel) may or may not substantially or entirely prevent blood-flow through channel sealing mechanism 2908. In some embodiments, mechanism 2908 may rely, at least in part, on blood clotting in order to form a seal. In some embodiments, mechanism 2908 (including a membrane, an iris mechanism, or collapsible walls) may form the seal (with or without assistance from blood clotting).

In some embodiments, top/luminal portion 2902 of occluder 2900 may be made from different material(s) (or the same material(s) but having different characteristics) than the material(s) used for bottom/outer portion 2904. For example, bottom/outer portion 2904 made be made from a coarser or more porous material than top/luminal portion 2902 to facilitate the formation of scar tissue on the outer portion. Bioabsorbable material(s) may also be used for portion 2902 and/or 2904 of occluder 2900 (e.g., magnesium and/or polydioxanone for a skeleton portion and/or polydioxanone, polyhydroxybutyrate, and/or gelatin as a filler).

FIG. 30 shows a perspective view of a guide wire 3000 for guiding the delivery of occluder 2900 to the access orifice. Guide wire 3000 may be the same guide wire used, for example, for a valve replacement surgery involving one of the delivery systems shown in FIGS. 22A-26C. FIG. 31 shows a perspective view of a threaded catheter 3100 for attaching to occluder 2900 during delivery and detaching from occluder 2900 once installation of the occluder is complete. As shown in FIGS. 32A and 32B, screw device 2906 of occluder 2900 may attach to threaded catheter 3100, and occluder 2900 may be loaded into second catheter 3202. For example, second catheter 3202 may be part of the delivery system (e.g., FIG. 26A-C) used for delivery of a replacement valve. Guide wire 3000 may extend through both the central channel of occluder 2900 and second catheter 3200. Guide wire 3000 may also be removable and reinsertable. FIG. 32B shows that the occluder can be partially unloaded by moving catheter 3100 relative to catheter 3202. Advantageously, if occluder 2900 is not positioned correctly upon partial release, it can be reloaded into catheter 3202 and relocated to the proper location within the access orifice without excessive manipulation of occluder 2900 and/or the associated delivery instruments.

FIGS. 33A and 33B illustrate side and perspective views of occluder 2900 in an expanded configuration within an access orifice in accordance with an embodiment of the present invention. Preferably, luminal/top portion 2902 and outer/bottom portion 2904 of occluder 2900 cover the access orifice completely. The central channel is also preferably sealed by, for example, a self-sealing membrane and/or sealing foam 2908.

Thus it is seen that stent-valves (e.g., single-stent-valves and double-stent-valves) and associated methods and systems for surgery are provided. Although particular embodiments have been disclosed herein in detail, this has been done by way of example for purposes of illustration only, and is not intended to be limiting with respect to the scope of the appended claims, which follow. In particular, it is contemplated by the inventors that various substitutions, alterations, and modifications may be made without departing from the spirit and scope of the invention as defined by the claims. Other aspects, advantages, and modifications are considered to be within the scope of the following claims. The claims presented are representative of the inventions disclosed herein. Other, unclaimed inventions are also contemplated. The inventors reserve the right to pursue such inventions in later claims.

Claims

1. A cardiac stent-valve device comprising: a stent component having a central axis, and an annular groove;a valve component housed in a section of the stent component;the stent component and the valve component being configured in a collapsed configuration for delivery at an implantation site, and in a self-expanding expanded configuration after delivery to the implantation site;wherein:the stent component comprises a lattice structure including a plurality of cells and a plurality of commissural posts, and a plurality of individual attachment elements projecting integrally from a stent extremity at a first axial end of the stent component,a commissure between two valve leaflets is attached to a respective commissural post,each attachment element is configured for removable attachment to a complimentary structure of a delivery system and corresponds to at least a portion of a respective commissural post,the annular groove is present in the expanded configuration, arranged towards a second axial end opposite the first axial end, and defined by an annular indentation of the stent component which correspondingly presents an indented interior surface of the stent component, andthe valve component extends axially beyond the annular groove towards the attachment elements.
2. The device of claim 1, wherein the cells of the lattice structure are closed.
3. The device of claim 1, wherein in the expanded configuration, the attachment elements project partially radially inwardly toward the central axis of the stent component.
4. The device of claim 3, wherein the attachment elements project partially inwardly toward the central axis on a diameter smaller than a diameter of the section of the stent component housing the valve component.
5. The device of claim 4, wherein the attachment elements are inclined with respect to the central axis to converge towards each other.
6. The device of claim 1, wherein the fully expanded diameter in a region of the attachment elements is smaller than a fully expanded diameter of the section that houses the valve component.
7. The device of claim 1, wherein each attachment element comprises a geometrical opening.
8. The device of claim 1, wherein the number of attachment elements is selected from: at least three and exactly three.
9. The device of claim 1, wherein the valve component is a tri-leaflet valve.
10. The device of claim 1, wherein an inflow end of the stent component is covered on its inner side with cloth.
11. The device of claim 10, wherein the cloth is sutured to the stent component in a region adjacent to the annular groove.
12. The device of claim 10, wherein the cloth is folded over to the exterior side of the stent component.
13. The device of claim 10, wherein commissures of the valve component are attached to corresponding commissure posts of the stent component that are covered with cloth.
14. A cardiac stent-valve system comprising: the stent-valve of claim 1; anda delivery system for delivering the cardiac stent-valve to an implantation site, the delivery system including a stent-holder,wherein the attachment elements are removably attached to the stent-holder of the delivery system.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a divisional of U.S. patent application Ser. No. 14/471,731, which was filed on Aug. 28, 2014; which is a continuation of U.S. patent application Ser. No. 13/433,910; which was filed Mar. 29, 2012, which is a divisional of U.S. patent application Ser. No. 11/700,922, filed on Dec. 21, 2006, which claims the benefit of U.S. Provisional Patent Application Nos. 60/753,071, filed Dec. 22, 2005, 60/755,590, filed Dec. 29, 2005, and 60/843,181, filed Sep. 7, 2006, each of which is hereby incorporated by reference in its entirety.

US Referenced Citations (1388)

Number	Name	Date	Kind
15192	Peale	Jun 1856	A
2682057	Lord	Jun 1954	A
2701559	Cooper	Feb 1955	A
2832078	Williams	Apr 1958	A
3029819	Starks	Apr 1962	A
3099016	Lowell	Jul 1963	A
3113586	Edmark	Dec 1963	A
3130418	Head et al.	Apr 1964	A
3143742	Cromie	Aug 1964	A
3221006	Moore et al.	Nov 1965	A
3334629	Cohn	Aug 1967	A
3365728	Edwards et al.	Jan 1968	A
3367364	Cruz et al.	Feb 1968	A
3409013	Henry	Nov 1968	A
3445916	Schulte	May 1969	A
3540431	Mobin-Uddin	Nov 1970	A
3548417	Kischer et al.	Dec 1970	A
3570014	Hancock	Mar 1971	A
3587115	Shiley	Jun 1971	A
3592184	Watkins et al.	Jul 1971	A
3628535	Ostrowsky et al.	Dec 1971	A
3642004	Osthagen et al.	Feb 1972	A
3657744	Ersek	Apr 1972	A
3671979	Moulopoulos	Jun 1972	A
3714671	Goodenough et al.	Feb 1973	A
3725961	Magovem et al.	Apr 1973	A
3755823	Hancock	Sep 1973	A
3795246	Sturgeon	Mar 1974	A
3839741	Haller	Oct 1974	A
3868956	Alfidi et al.	Mar 1975	A
3874388	King et al.	Apr 1975	A
3983581	Angell et al.	Oct 1976	A
3997923	Possis	Dec 1976	A
4035849	Angell et al.	Jul 1977	A
4056854	Boretos et al.	Nov 1977	A
4084268	Ionescu et al.	Apr 1978	A
4106129	Carpentier et al.	Aug 1978	A
4191218	Clark et al.	Mar 1980	A
4222126	Boretos et al.	Sep 1980	A
4233690	Akins	Nov 1980	A
4265694	Boretos et al.	May 1981	A
4291420	Reul	Sep 1981	A
4297749	Davis et al.	Nov 1981	A
4323358	Lentz et al.	Apr 1982	A
4326306	Poler	Apr 1982	A
4339831	Johnson	Jul 1982	A
4343048	Ross et al.	Aug 1982	A
4345340	Rosen	Aug 1982	A
4373216	Klawitter	Feb 1983	A
4406022	Roy	Sep 1983	A
4423809	Mazzocco	Jan 1984	A
4425908	Simon	Jan 1984	A
4470157	Love	Sep 1984	A
4484579	Meno et al.	Nov 1984	A
4501030	Lane	Feb 1985	A
4531943	Tassel et al.	Jul 1985	A
4535483	Klawitter et al.	Aug 1985	A
4574803	Storz	Mar 1986	A
4580568	Gianturco	Apr 1986	A
4592340	Boyles	Jun 1986	A
4602911	Ahmadi et al.	Jul 1986	A
4605407	Black et al.	Aug 1986	A
4610688	Silvestrini et al.	Sep 1986	A
4612011	Kautzky	Sep 1986	A
4617932	Kornberg	Oct 1986	A
4643732	Pietsch et al.	Feb 1987	A
4647283	Carpentier et al.	Mar 1987	A
4648881	Carpentier et al.	Mar 1987	A
4655218	Kulik et al.	Apr 1987	A
4655771	Wallsten et al.	Apr 1987	A
4662885	DiPisa	May 1987	A
4665906	Jervis	May 1987	A
4680031	Alonso	Jul 1987	A
4692164	Dzemeshkevich et al.	Sep 1987	A
4705516	Barone et al.	Nov 1987	A
4710192	Liotta et al.	Dec 1987	A
4733665	Palmaz et al.	Mar 1988	A
4755181	Igoe	Jul 1988	A
4759758	Gabbay	Jul 1988	A
4777951	Cribier et al.	Oct 1988	A
4787899	Lazarus	Nov 1988	A
4787901	Baykut	Nov 1988	A
4796629	Grayzel	Jan 1989	A
4819751	Shimada et al.	Apr 1989	A
4829990	Thuroff et al.	May 1989	A
4834755	Silvestrini et al.	May 1989	A
4851001	Taheri	Jul 1989	A
4856516	Hillstead	Aug 1989	A
4865600	Carpentier et al.	Sep 1989	A
4872874	Taheri	Oct 1989	A
4873978	Ginsburg	Oct 1989	A
4878495	Grayzel	Nov 1989	A
4878906	Lindemann et al.	Nov 1989	A
4883458	Shiber	Nov 1989	A
4885005	Nashef et al.	Dec 1989	A
4909252	Goldberger	Mar 1990	A
4917102	Miller et al.	Apr 1990	A
4922905	Strecker	May 1990	A
4927426	Dretler	May 1990	A
4954126	Wallsten	Sep 1990	A
4966604	Reiss	Oct 1990	A
4969890	Sugita et al.	Nov 1990	A
4979939	Shiber	Dec 1990	A
4986830	Owens et al.	Jan 1991	A
4994077	Dobben	Feb 1991	A
5002556	Ishida et al.	Mar 1991	A
5002559	Tower	Mar 1991	A
5002566	Carpentier et al.	Mar 1991	A
5007896	Shiber	Apr 1991	A
5026366	Leckrone	Jun 1991	A
5032128	Alonso	Jul 1991	A
5037434	Lane	Aug 1991	A
5047041	Samuels	Sep 1991	A
5061277	Carpentier et al.	Oct 1991	A
5064435	Porter	Nov 1991	A
5078720	Burton et al.	Jan 1992	A
5080668	Bolz et al.	Jan 1992	A
5085635	Cragg	Feb 1992	A
5089015	Ross	Feb 1992	A
5094661	Levy et al.	Mar 1992	A
5104407	Lam et al.	Apr 1992	A
5122154	Rhodes	Jun 1992	A
5132473	Furutaka et al.	Jul 1992	A
5141494	Danforth et al.	Aug 1992	A
5152771	Sabbaghian et al.	Oct 1992	A
5159937	Tremulis	Nov 1992	A
5161547	Tower	Nov 1992	A
5163953	Vince	Nov 1992	A
5163955	Love et al.	Nov 1992	A
5167628	Boyles	Dec 1992	A
5192301	Kamiya et al.	Mar 1993	A
5197979	Quintero et al.	Mar 1993	A
5209741	Spaeth	May 1993	A
5215541	Nashef et al.	Jun 1993	A
5217481	Barbara	Jun 1993	A
5217483	Tower	Jun 1993	A
5238004	Sahatjian et al.	Aug 1993	A
5258023	Reger	Nov 1993	A
5258042	Mehta	Nov 1993	A
5272909	Nguyen et al.	Dec 1993	A
5279612	Eberhardt	Jan 1994	A
5282847	Trescony et al.	Feb 1994	A
5295958	Shturman	Mar 1994	A
5327774	Nguyen et al.	Jul 1994	A
5332402	Teitelbaum	Jul 1994	A
5336258	Quintero et al.	Aug 1994	A
5344442	Deac	Sep 1994	A
5350398	Pavcnik et al.	Sep 1994	A
5352240	Ross	Oct 1994	A
5354330	Hanson et al.	Oct 1994	A
5360444	Kusuhara	Nov 1994	A
5368608	Levy et al.	Nov 1994	A
5370685	Stevens	Dec 1994	A
5389106	Tower	Feb 1995	A
5397351	Pavcnik et al.	Mar 1995	A
5409019	Wilk	Apr 1995	A
5411552	Andersen et al.	May 1995	A
5425739	Jessen	Jun 1995	A
5425762	Muller	Jun 1995	A
5431676	Dubrul et al.	Jul 1995	A
5443446	Shturman	Aug 1995	A
5443449	Buelna	Aug 1995	A
5443477	Mann et al.	Aug 1995	A
5443495	Buscemi et al.	Aug 1995	A
5443499	Schmitt	Aug 1995	A
5456713	Chuter	Oct 1995	A
5469868	Reger	Nov 1995	A
5476506	Lunn	Dec 1995	A
5476510	Eberhardt et al.	Dec 1995	A
5480423	Ravenscroft et al.	Jan 1996	A
5480424	Cox	Jan 1996	A
5487760	Villafana	Jan 1996	A
5489297	Duran	Feb 1996	A
5499995	Teirstein	Mar 1996	A
5500014	Quijano et al.	Mar 1996	A
5500015	Deac	Mar 1996	A
5507767	Maeda et al.	Apr 1996	A
5509930	Love	Apr 1996	A
5522881	Lentz	Jun 1996	A
5534007	St. Germain et al.	Jul 1996	A
5540712	Kleshinski et al.	Jul 1996	A
5545133	Burns et al.	Aug 1996	A
5545209	Roberts et al.	Aug 1996	A
5545211	An et al.	Aug 1996	A
5545214	Stevens	Aug 1996	A
5549665	Vesely et al.	Aug 1996	A
5549666	Hata et al.	Aug 1996	A
5554185	Block et al.	Sep 1996	A
5569274	Rapacki et al.	Oct 1996	A
5571174	Love et al.	Nov 1996	A
5571175	Vanney et al.	Nov 1996	A
5571215	Sterman et al.	Nov 1996	A
5573520	Schwartz et al.	Nov 1996	A
5575818	Pinchuk	Nov 1996	A
5591185	Kilmer et al.	Jan 1997	A
5591195	Taheri et al.	Jan 1997	A
5595571	Jaffe et al.	Jan 1997	A
5607464	Trescony et al.	Mar 1997	A
5609626	Quijano et al.	Mar 1997	A
5613982	Goldstein	Mar 1997	A
5628784	Strecker	May 1997	A
5632778	Goldstein	May 1997	A
5645559	Hachtman et al.	Jul 1997	A
5653745	Trescony et al.	Aug 1997	A
5653749	Love et al.	Aug 1997	A
5662671	Barbut et al.	Sep 1997	A
5662703	Yurek et al.	Sep 1997	A
5667523	Bynon et al.	Sep 1997	A
5674277	Freitag	Oct 1997	A
5674298	Levy et al.	Oct 1997	A
5679112	Levy et al.	Oct 1997	A
5681345	Euteneuer	Oct 1997	A
5682906	Sterman et al.	Nov 1997	A
5683451	Lenker et al.	Nov 1997	A
5693083	Baker et al.	Dec 1997	A
5693088	Lazarus	Dec 1997	A
5693310	Gries et al.	Dec 1997	A
5695498	Tower	Dec 1997	A
5697972	Kim et al.	Dec 1997	A
5709713	Evans et al.	Jan 1998	A
5713950	Cox	Feb 1998	A
5713951	Garrison et al.	Feb 1998	A
5713953	Vallana et al.	Feb 1998	A
5716370	Williamson, IV et al.	Feb 1998	A
5716417	Girard et al.	Feb 1998	A
5718725	Sterman et al.	Feb 1998	A
5720391	Dohm et al.	Feb 1998	A
5725549	Lam	Mar 1998	A
5728068	Leone et al.	Mar 1998	A
5728151	Garrison et al.	Mar 1998	A
5733325	Robinson et al.	Mar 1998	A
5735842	Krueger et al.	Apr 1998	A
5746765	Kleshinski et al.	May 1998	A
5746775	Levy et al.	May 1998	A
5749890	Shaknovich	May 1998	A
5755777	Chuter	May 1998	A
5755783	Stobie et al.	May 1998	A
5756476	Epstein et al.	May 1998	A
5769812	Stevens et al.	Jun 1998	A
5769882	Fogarty et al.	Jun 1998	A
5772609	Nguyen et al.	Jun 1998	A
5776188	Shepherd et al.	Jul 1998	A
5782904	White et al.	Jul 1998	A
5797960	Stevens et al.	Aug 1998	A
5799661	Boyd et al.	Sep 1998	A
5800456	Maeda et al.	Sep 1998	A
5800531	Cosgrove et al.	Sep 1998	A
5807327	Green et al.	Sep 1998	A
5807405	Vanney et al.	Sep 1998	A
5814016	Valley et al.	Sep 1998	A
5817126	Imran	Oct 1998	A
5823956	Roth et al.	Oct 1998	A
5824037	Fogarty et al.	Oct 1998	A
5824041	Lenker et al.	Oct 1998	A
5824043	Cottone	Oct 1998	A
5824053	Khosravi et al.	Oct 1998	A
5824055	Spiridigliozzi et al.	Oct 1998	A
5824056	Rosenberg	Oct 1998	A
5824061	Quijano et al.	Oct 1998	A
5824063	Cox	Oct 1998	A
5824064	Taheri	Oct 1998	A
5824080	Lamuraglia	Oct 1998	A
5829447	Stevens et al.	Nov 1998	A
5840081	Andersen et al.	Nov 1998	A
5841382	Walden et al.	Nov 1998	A
5843158	Lenker et al.	Dec 1998	A
5843161	Solovay	Dec 1998	A
5843181	Jaffe et al.	Dec 1998	A
5855210	Sterman et al.	Jan 1999	A
5855597	Jayaraman	Jan 1999	A
5855600	Alt	Jan 1999	A
5855601	Bessler et al.	Jan 1999	A
5855602	Angell	Jan 1999	A
5860966	Tower	Jan 1999	A
5860996	Urban et al.	Jan 1999	A
5861024	Rashidi	Jan 1999	A
5861028	Angell	Jan 1999	A
5868783	Tower	Feb 1999	A
5876419	Carpenter et al.	Mar 1999	A
5876434	Flomenblit et al.	Mar 1999	A
5876448	Thompson et al.	Mar 1999	A
5880242	Hu et al.	Mar 1999	A
5885228	Rosenman et al.	Mar 1999	A
5888201	Stinson et al.	Mar 1999	A
5891191	Stinson	Apr 1999	A
5895399	Barbut et al.	Apr 1999	A
5899936	Goldstein	May 1999	A
5906619	Olson et al.	May 1999	A
5907893	Zadno-Azizi et al.	Jun 1999	A
5910154	Tsugita et al.	Jun 1999	A
5911734	Tsugita et al.	Jun 1999	A
5924424	Stevens et al.	Jul 1999	A
5925063	Khosravi	Jul 1999	A
5928281	Huynh et al.	Jul 1999	A
5935163	Gabbay	Aug 1999	A
5938697	Killion et al.	Aug 1999	A
5944738	Amplatz et al.	Aug 1999	A
5954766	Zadno-Azizi et al.	Sep 1999	A
5957949	Leonhardt et al.	Sep 1999	A
5968070	Bley et al.	Oct 1999	A
5976174	Ruiz	Nov 1999	A
5980455	Daniel et al.	Nov 1999	A
5980533	Holman	Nov 1999	A
5984957	Laptewicz et al.	Nov 1999	A
5984959	Robertson et al.	Nov 1999	A
5993469	McKenzie et al.	Nov 1999	A
5997557	Barbut et al.	Dec 1999	A
5997573	Quijano et al.	Dec 1999	A
6001126	Nguyen-Thien-Nhon	Dec 1999	A
6010522	Barbut et al.	Jan 2000	A
6010531	Donlon et al.	Jan 2000	A
6015431	Thornton et al.	Jan 2000	A
6022370	Tower	Feb 2000	A
6027476	Sterman et al.	Feb 2000	A
6027520	Tsugita et al.	Feb 2000	A
6027525	Suh et al.	Feb 2000	A
6029671	Stevens et al.	Feb 2000	A
6042598	Tsugita et al.	Mar 2000	A
6042607	Williamson, IV et al.	Mar 2000	A
6051014	Jang	Apr 2000	A
6059827	Fenton	May 2000	A
6074418	Buchanan et al.	Jun 2000	A
6077297	Robinson et al.	Jun 2000	A
6079414	Roth	Jun 2000	A
6083257	Taylor et al.	Jul 2000	A
6092529	Cox	Jul 2000	A
6093203	Uflacker	Jul 2000	A
6093530	McIlroy et al.	Jul 2000	A
6096074	Pedros	Aug 2000	A
6102944	Huynh et al.	Aug 2000	A
6110191	Dehdashtian et al.	Aug 2000	A
6110198	Fogarty et al.	Aug 2000	A
6110201	Quijano et al.	Aug 2000	A
6117169	Moe	Sep 2000	A
6123723	Konya et al.	Sep 2000	A
6125852	Stevens et al.	Oct 2000	A
6126685	Lenker et al.	Oct 2000	A
6132473	Williams et al.	Oct 2000	A
6139510	Palermo	Oct 2000	A
6142987	Tsugita	Nov 2000	A
6146366	Schachar	Nov 2000	A
6162245	Jayaraman	Dec 2000	A
6165200	Tsugita et al.	Dec 2000	A
6165209	Patterson et al.	Dec 2000	A
6168579	Tsugita	Jan 2001	B1
6168614	Andersen et al.	Jan 2001	B1
6171327	Daniel et al.	Jan 2001	B1
6171335	Wheatley et al.	Jan 2001	B1
6177514	Pathak et al.	Jan 2001	B1
6179859	Bates et al.	Jan 2001	B1
6182664	Cosgrove	Feb 2001	B1
6183481	Lee et al.	Feb 2001	B1
6187016	Hedges et al.	Feb 2001	B1
6196230	Hall et al.	Mar 2001	B1
6197053	Cosgrove et al.	Mar 2001	B1
6200336	Pavcnik et al.	Mar 2001	B1
6206911	Milo	Mar 2001	B1
6214036	Letendre et al.	Apr 2001	B1
6214055	Simionescu et al.	Apr 2001	B1
6221006	Dubrul et al.	Apr 2001	B1
6221091	Khosravi	Apr 2001	B1
6221096	Aiba et al.	Apr 2001	B1
6221100	Strecker	Apr 2001	B1
6231544	Tsugita et al.	May 2001	B1
6231551	Barbut	May 2001	B1
6231602	Carpentier et al.	May 2001	B1
6241757	An et al.	Jun 2001	B1
6245102	Jayaraman	Jun 2001	B1
6245105	Nguyen et al.	Jun 2001	B1
6251135	Stinson et al.	Jun 2001	B1
6254564	Wilk et al.	Jul 2001	B1
6254636	Peredo	Jul 2001	B1
6258114	Konya et al.	Jul 2001	B1
6258115	Dubrul	Jul 2001	B1
6258120	McKenzie et al.	Jul 2001	B1
6258129	Dybdal et al.	Jul 2001	B1
6267783	Letendre et al.	Jul 2001	B1
6269819	Oz et al.	Aug 2001	B1
6270513	Tsugita et al.	Aug 2001	B1
6270526	Cox	Aug 2001	B1
6277555	Duran et al.	Aug 2001	B1
6283127	Sterman et al.	Sep 2001	B1
6283995	Moe et al.	Sep 2001	B1
6287334	Moll et al.	Sep 2001	B1
6287338	Samowski et al.	Sep 2001	B1
6287339	Vazquez et al.	Sep 2001	B1
6299637	Shaolian et al.	Oct 2001	B1
6302906	Goicoechea et al.	Oct 2001	B1
6306164	Kujawski	Oct 2001	B1
6309417	Spence et al.	Oct 2001	B1
6311693	Sterman et al.	Nov 2001	B1
6312465	Griffin et al.	Nov 2001	B1
6319281	Patel	Nov 2001	B1
6325067	Sterman et al.	Dec 2001	B1
6327772	Zadno-Azizi et al.	Dec 2001	B1
6331189	Wolinsky et al.	Dec 2001	B1
6336934	Gilson et al.	Jan 2002	B1
6336937	Vonesh et al.	Jan 2002	B1
6338735	Stevens	Jan 2002	B1
6338740	Carpentier	Jan 2002	B1
6342070	Nguyen-Thien-Nhon	Jan 2002	B1
6344044	Fulkerson et al.	Feb 2002	B1
6346074	Roth	Feb 2002	B1
6346116	Brooks et al.	Feb 2002	B1
6348063	Yassour et al.	Feb 2002	B1
6350278	Lenker et al.	Feb 2002	B1
6352554	Paulis	Mar 2002	B2
6352708	Duran et al.	Mar 2002	B1
6361545	Macoviak et al.	Mar 2002	B1
6363938	Saadat et al.	Apr 2002	B2
6364895	Greenhalgh	Apr 2002	B1
6371970	Khosravi et al.	Apr 2002	B1
6371983	Lane	Apr 2002	B1
6378221	Ekholm, Jr. et al.	Apr 2002	B1
6379372	Dehdashtian et al.	Apr 2002	B1
6379383	Palmaz et al.	Apr 2002	B1
6379740	Rinaldi et al.	Apr 2002	B1
6387122	Cragg	May 2002	B1
6391538	Vyavahare et al.	May 2002	B1
6398807	Chouinard et al.	Jun 2002	B1
6401720	Stevens et al.	Jun 2002	B1
6402736	Brown et al.	Jun 2002	B1
6406493	Tu et al.	Jun 2002	B1
6409750	Hyodoh et al.	Jun 2002	B1
6409759	Peredo	Jun 2002	B1
6416510	Altman et al.	Jul 2002	B1
6425916	Garrison et al.	Jul 2002	B1
6440164	DiMatteo et al.	Aug 2002	B1
6451054	Stevens	Sep 2002	B1
6454799	Schreck	Sep 2002	B1
6458153	Bailey et al.	Oct 2002	B1
6461382	Cao	Oct 2002	B1
6468303	Amplatz et al.	Oct 2002	B1
6468660	Ogle et al.	Oct 2002	B2
6471723	Ashworth et al.	Oct 2002	B1
6475239	Campbell et al.	Nov 2002	B1
6478819	Moe	Nov 2002	B2
6482228	Norred	Nov 2002	B1
6485501	Green	Nov 2002	B1
6485502	Michael et al.	Nov 2002	B2
6488704	Connelly et al.	Dec 2002	B1
6494211	Boyd et al.	Dec 2002	B1
6494897	Sterman et al.	Dec 2002	B2
6494909	Greenhalgh	Dec 2002	B2
6503272	Duerig et al.	Jan 2003	B2
6508803	Horikawa et al.	Jan 2003	B1
6508833	Pavcnik et al.	Jan 2003	B2
6509145	Torrianni	Jan 2003	B1
6521179	Girardot et al.	Feb 2003	B1
6527800	McGuckin et al.	Mar 2003	B1
6530949	Konya et al.	Mar 2003	B2
6530952	Vesely	Mar 2003	B2
6533807	Wolinsky et al.	Mar 2003	B2
6537297	Tsugita et al.	Mar 2003	B2
6537310	Palmaz et al.	Mar 2003	B1
6540768	Diaz et al.	Apr 2003	B1
6540782	Snyders	Apr 2003	B1
6558318	Daniel et al.	May 2003	B1
6558417	Peredo	May 2003	B2
6558418	Carpentier et al.	May 2003	B2
6562058	Seguin et al.	May 2003	B2
6562069	Cai et al.	May 2003	B2
6564805	Garrison et al.	May 2003	B2
6569196	Vesely	May 2003	B1
6572642	Rinaldi et al.	Jun 2003	B2
6572643	Gharibadeh	Jun 2003	B1
6572652	Shaknovich	Jun 2003	B2
6582462	Andersen et al.	Jun 2003	B1
6585766	Huynh et al.	Jul 2003	B1
6589279	Anderson et al.	Jul 2003	B1
6592546	Barbut et al.	Jul 2003	B1
6592614	Lenker et al.	Jul 2003	B2
6605112	Moll et al.	Aug 2003	B1
6610077	Hancock et al.	Aug 2003	B1
6613069	Boyd et al.	Sep 2003	B2
6613079	Wolinsky et al.	Sep 2003	B1
6613086	Moe et al.	Sep 2003	B1
6616682	Joergensen et al.	Sep 2003	B2
6622604	Chouinard et al.	Sep 2003	B1
6623518	Thompson et al.	Sep 2003	B2
6623521	Steinke et al.	Sep 2003	B2
6626938	Butaric et al.	Sep 2003	B1
6632243	Zadno-Azizi et al.	Oct 2003	B1
6635068	Dubrul et al.	Oct 2003	B1
6635079	Unsworth et al.	Oct 2003	B2
6635080	Lauterjung et al.	Oct 2003	B1
6635085	Caffey et al.	Oct 2003	B1
6651672	Roth	Nov 2003	B2
6652555	VanTassel et al.	Nov 2003	B1
6652571	White et al.	Nov 2003	B1
6652578	Bailey et al.	Nov 2003	B2
6663588	DuBois et al.	Dec 2003	B2
6663663	Kim et al.	Dec 2003	B2
6663667	Dehdashtian et al.	Dec 2003	B2
6669724	Park et al.	Dec 2003	B2
6673089	Yassour et al.	Jan 2004	B1
6673109	Cox	Jan 2004	B2
6676668	Mercereau et al.	Jan 2004	B2
6676692	Rabkin et al.	Jan 2004	B2
6676698	McGuckin et al.	Jan 2004	B2
6679268	Stevens et al.	Jan 2004	B2
6682543	Barbut et al.	Jan 2004	B2
6682558	Tu et al.	Jan 2004	B2
6682559	Myers et al.	Jan 2004	B2
6685739	DiMatteo et al.	Feb 2004	B2
6689144	Gerberding	Feb 2004	B2
6689164	Seguin	Feb 2004	B1
6692512	Jang	Feb 2004	B2
6695864	Macoviak et al.	Feb 2004	B2
6695865	Boyle et al.	Feb 2004	B2
6695875	Stelter et al.	Feb 2004	B2
6702851	Chinn et al.	Mar 2004	B1
6712842	Gifford et al.	Mar 2004	B1
6712843	Elliott	Mar 2004	B2
6714842	Ito	Mar 2004	B1
6719787	Cox	Apr 2004	B2
6719788	Cox	Apr 2004	B2
6719789	Cox	Apr 2004	B2
6723116	Taheri	Apr 2004	B2
6723122	Yang et al.	Apr 2004	B2
6729356	Baker et al.	May 2004	B1
6730118	Spenser et al.	May 2004	B2
6730377	Wang	May 2004	B2
6733513	Boyle et al.	May 2004	B2
6733525	Yang et al.	May 2004	B2
6736827	McAndrew et al.	May 2004	B1
6736845	Marquez et al.	May 2004	B2
6736846	Cox	May 2004	B2
6752828	Thornton	Jun 2004	B2
6755854	Gillick et al.	Jun 2004	B2
6755855	Yurek et al.	Jun 2004	B2
6758855	Fulton	Jul 2004	B2
6764503	Ishimaru	Jul 2004	B1
6764509	Chinn et al.	Jul 2004	B2
6767345	Germain et al.	Jul 2004	B2
6767362	Schreck	Jul 2004	B2
6769434	Liddicoat et al.	Aug 2004	B2
6773454	Wholey et al.	Aug 2004	B2
6773456	Gordon et al.	Aug 2004	B1
6776791	Stallings et al.	Aug 2004	B1
6786925	Schoon et al.	Sep 2004	B1
6790229	Berreklouw	Sep 2004	B1
6790230	Beyersdorf et al.	Sep 2004	B2
6790237	Stinson	Sep 2004	B2
6792979	Konya et al.	Sep 2004	B2
6797002	Spence et al.	Sep 2004	B2
6802319	Stevens et al.	Oct 2004	B2
6805711	Quijano et al.	Oct 2004	B2
6808529	Fulkerson	Oct 2004	B2
6814746	Thompson et al.	Nov 2004	B2
6814754	Greenhalgh	Nov 2004	B2
6820676	Palmaz et al.	Nov 2004	B2
6821297	Snyders	Nov 2004	B2
6824041	Grieder et al.	Nov 2004	B2
6824970	Vyavahare et al.	Nov 2004	B2
6830584	Seguin	Dec 2004	B1
6830585	Artof et al.	Dec 2004	B1
6830586	Quijano et al.	Dec 2004	B2
6837901	Rabkin et al.	Jan 2005	B2
6840957	DiMatteo et al.	Jan 2005	B2
6843802	Villalobos et al.	Jan 2005	B1
6849085	Marton	Feb 2005	B2
6861211	Levy et al.	Mar 2005	B2
6863668	Gillespie et al.	Mar 2005	B2
6863688	Ralph et al.	Mar 2005	B2
6866650	Stevens et al.	Mar 2005	B2
6866669	Buzzard et al.	Mar 2005	B2
6872223	Roberts et al.	Mar 2005	B2
6872226	Cali et al.	Mar 2005	B2
6875231	Anduiza et al.	Apr 2005	B2
6881199	Wilk et al.	Apr 2005	B2
6881220	Edwin et al.	Apr 2005	B2
6887266	Williams et al.	May 2005	B2
6890340	Duane	May 2005	B2
6893459	Macoviak	May 2005	B1
6893460	Spenser et al.	May 2005	B2
6896690	Lambrecht et al.	May 2005	B1
6899704	Sterman et al.	May 2005	B2
6905743	Chen et al.	Jun 2005	B1
6908481	Cribier	Jun 2005	B2
6911036	Douk et al.	Jun 2005	B2
6911040	Johnson et al.	Jun 2005	B2
6911043	Myers et al.	Jun 2005	B2
6936058	Forde et al.	Aug 2005	B2
6936066	Palmaz et al.	Aug 2005	B2
6936067	Buchanan	Aug 2005	B2
6939352	Buzzard et al.	Sep 2005	B2
6939359	Tu et al.	Sep 2005	B2
6942682	Vrba et al.	Sep 2005	B2
6951571	Srivastava	Oct 2005	B1
6953332	Kurk et al.	Oct 2005	B1
6955175	Stevens et al.	Oct 2005	B2
6964673	Tsugita et al.	Nov 2005	B2
6969395	Eskuri	Nov 2005	B2
6972025	WasDyke	Dec 2005	B2
6974464	Quijano et al.	Dec 2005	B2
6974474	Pavcnik et al.	Dec 2005	B2
6974476	McGuckin et al.	Dec 2005	B2
6979350	Moll et al.	Dec 2005	B2
6984242	Campbell et al.	Jan 2006	B2
6989027	Allen et al.	Jan 2006	B2
7004176	Lau	Feb 2006	B2
7011681	Vesely	Mar 2006	B2
7014655	Barbarash et al.	Mar 2006	B2
7018406	Seguin et al.	Mar 2006	B2
7018408	Bailey et al.	Mar 2006	B2
7022134	Quijano et al.	Apr 2006	B1
7025773	Gittings et al.	Apr 2006	B2
7025780	Gabbay	Apr 2006	B2
7025791	Levine et al.	Apr 2006	B2
7028692	Sterman et al.	Apr 2006	B2
7037331	Mitelberg et al.	May 2006	B2
7037333	Myers et al.	May 2006	B2
7041132	Quijano et al.	May 2006	B2
7044966	Svanidze et al.	May 2006	B2
7048757	Shaknovich	May 2006	B2
7050276	Nishiyama	May 2006	B2
7078163	Torrianni	Jul 2006	B2
7081132	Cook et al.	Jul 2006	B2
7097658	Oktay	Aug 2006	B2
7101396	Artof et al.	Sep 2006	B2
7108715	Lawrence-Brown et al.	Sep 2006	B2
7118585	Addis	Oct 2006	B2
7122020	Mogul	Oct 2006	B2
7125418	Duran et al.	Oct 2006	B2
7137184	Schreck	Nov 2006	B2
7141063	White et al.	Nov 2006	B2
7141064	Scott et al.	Nov 2006	B2
7147663	Berg et al.	Dec 2006	B1
7163556	Xie et al.	Jan 2007	B2
7166097	Barbut	Jan 2007	B2
7175652	Cook et al.	Feb 2007	B2
7175653	Gaber	Feb 2007	B2
7175654	Bonsignore et al.	Feb 2007	B2
7175656	Khairkhahan	Feb 2007	B2
7179290	Cao	Feb 2007	B2
7189258	Johnson et al.	Mar 2007	B2
7189259	Simionesou et al.	Mar 2007	B2
7191018	Gielen et al.	Mar 2007	B2
7195641	Palmaz et al.	Mar 2007	B2
7198646	Figulla et al.	Apr 2007	B2
7201772	Schwammenthal et al.	Apr 2007	B2
7214344	Carpentier et al.	May 2007	B2
7217287	Wilson et al.	May 2007	B2
7235092	Banas et al.	Jun 2007	B2
7235093	Gregorich	Jun 2007	B2
7238200	Lee et al.	Jul 2007	B2
7252682	Seguin	Aug 2007	B2
7258696	Rabkin et al.	Aug 2007	B2
7261732	Justino	Aug 2007	B2
7264632	Wright et al.	Sep 2007	B2
7267686	DiMatteo et al.	Sep 2007	B2
7276078	Spenser et al.	Oct 2007	B2
7276084	Yang et al.	Oct 2007	B2
7285130	Austin	Oct 2007	B2
7314449	Pfeiffer et al.	Jan 2008	B2
7314485	Mathis	Jan 2008	B2
7314880	Chang et al.	Jan 2008	B2
7316712	Peredo	Jan 2008	B2
7317005	Hoekstra et al.	Jan 2008	B2
7317942	Brown	Jan 2008	B2
7317950	Lee	Jan 2008	B2
7318278	Zhang et al.	Jan 2008	B2
7318998	Goldstein et al.	Jan 2008	B2
7319096	Maim et al.	Jan 2008	B2
7320692	Bender et al.	Jan 2008	B1
7320704	Lashinski et al.	Jan 2008	B2
7320705	Quintessenza	Jan 2008	B2
7320706	Al-Najjar	Jan 2008	B2
7322932	Xie et al.	Jan 2008	B2
7326174	Cox et al.	Feb 2008	B2
7326219	Mowry et al.	Feb 2008	B2
7326236	Andreas et al.	Feb 2008	B2
7327862	Murphy et al.	Feb 2008	B2
7329278	Seguin et al.	Feb 2008	B2
7329279	Haug et al.	Feb 2008	B2
7329280	Bolling et al.	Feb 2008	B2
7329777	Harter et al.	Feb 2008	B2
7331991	Kheradvar et al.	Feb 2008	B2
7331993	White	Feb 2008	B2
7333643	Murphy et al.	Feb 2008	B2
7335158	Taylor	Feb 2008	B2
7335213	Hyde et al.	Feb 2008	B1
7335490	Van Gilst et al.	Feb 2008	B2
7338484	Schoon et al.	Mar 2008	B2
7361189	Case et al.	Apr 2008	B2
7361190	Shaoulian et al.	Apr 2008	B2
7364588	Mathis et al.	Apr 2008	B2
7371258	Woo et al.	May 2008	B2
7374560	Ressemann et al.	May 2008	B2
7374571	Pease et al.	May 2008	B2
7377895	Spence et al.	May 2008	B2
7377938	Sarac et al.	May 2008	B2
7377940	Ryan et al.	May 2008	B2
7381210	Zarbatany et al.	Jun 2008	B2
7381218	Schreck	Jun 2008	B2
7381219	Salahieh et al.	Jun 2008	B2
7381220	Macoviak et al.	Jun 2008	B2
7389874	Quest et al.	Jun 2008	B2
7390325	Wang et al.	Jun 2008	B2
7393358	Malewicz	Jul 2008	B2
7393360	Spenser et al.	Jul 2008	B2
7396364	Moaddeb et al.	Jul 2008	B2
7399315	Iobbi	Jul 2008	B2
7402171	Osborne et al.	Jul 2008	B2
7404792	Spence et al.	Jul 2008	B2
7404793	Lau et al.	Jul 2008	B2
7410499	Bicer	Aug 2008	B2
7412274	Mejia	Aug 2008	B2
7412290	Janke et al.	Aug 2008	B2
7415861	Sokel	Aug 2008	B2
7416530	Turner et al.	Aug 2008	B2
7422603	Lane	Sep 2008	B2
7422606	Ung-Chhun et al.	Sep 2008	B2
7423032	Ozaki et al.	Sep 2008	B2
7426413	Balczewski et al.	Sep 2008	B2
7427279	Frazier et al.	Sep 2008	B2
7427287	Turovskiy et al.	Sep 2008	B2
7427291	Liddicoat et al.	Sep 2008	B2
7430448	Zimmer et al.	Sep 2008	B1
7431691	Wilk	Oct 2008	B1
7431733	Knight	Oct 2008	B2
7435059	Smith et al.	Oct 2008	B2
7435257	Lashinski et al.	Oct 2008	B2
7445630	Lashinski et al.	Nov 2008	B2
7445631	Salahieh et al.	Nov 2008	B2
7445632	McGuckin, Jr. et al.	Nov 2008	B2
7452371	Pavcnik et al.	Nov 2008	B2
7455689	Johnson	Nov 2008	B2
7462156	Mitrev	Dec 2008	B2
7462184	Worley et al.	Dec 2008	B2
7462191	Spenser et al.	Dec 2008	B2
7468050	Kantrowitz	Dec 2008	B1
7470284	Lambrecht et al.	Dec 2008	B2
7470285	Nugent et al.	Dec 2008	B2
7473275	Marquez	Jan 2009	B2
7473417	Zeltinger et al.	Jan 2009	B2
7476196	Spence et al.	Jan 2009	B2
7476199	Spence et al.	Jan 2009	B2
7476200	Tal	Jan 2009	B2
7481838	Carpentier et al.	Jan 2009	B2
7485088	Murphy et al.	Feb 2009	B2
7485143	Webler et al.	Feb 2009	B2
7488346	Navia	Feb 2009	B2
7491232	Bolduc et al.	Feb 2009	B2
7497824	Taylor	Mar 2009	B2
7500949	Gottlieb et al.	Mar 2009	B2
7500989	Solem et al.	Mar 2009	B2
7503929	Johnson et al.	Mar 2009	B2
7503930	Sharkawy et al.	Mar 2009	B2
7507199	Wang et al.	Mar 2009	B2
7510572	Gabbay	Mar 2009	B2
7510574	Lê et al.	Mar 2009	B2
7510575	Spenser et al.	Mar 2009	B2
7510577	Moaddeb et al.	Mar 2009	B2
7513863	Bolling et al.	Apr 2009	B2
7513909	Lane et al.	Apr 2009	B2
7522950	Fuimaono et al.	Apr 2009	B2
7524330	Berreklouw	Apr 2009	B2
7530253	Spenser et al.	May 2009	B2
7530995	Quijano et al.	May 2009	B2
7534261	Friedman	May 2009	B2
7544206	Cohn	Jun 2009	B2
7556646	Yang et al.	Jul 2009	B2
7578828	Gittings et al.	Aug 2009	B2
7585321	Cribier	Sep 2009	B2
7591848	Allen	Sep 2009	B2
7601159	Ewers et al.	Oct 2009	B2
7618446	Andersen et al.	Nov 2009	B2
7622276	Cunanan et al.	Nov 2009	B2
7625403	Krivoruchko	Dec 2009	B2
7628802	White et al.	Dec 2009	B2
7628803	Pavcnik et al.	Dec 2009	B2
7632296	Malewicz	Dec 2009	B2
7632298	Hijlkema et al.	Dec 2009	B2
7641687	Chinn et al.	Jan 2010	B2
7674282	Wu et al.	Mar 2010	B2
7682390	Seguin	Mar 2010	B2
7712606	Salahieh et al.	May 2010	B2
7722638	Deyette et al.	May 2010	B2
7722662	Steinke et al.	May 2010	B2
7722666	Lafontaine	May 2010	B2
7731742	Schlick et al.	Jun 2010	B2
7736388	Goldfarb et al.	Jun 2010	B2
7748389	Salahieh et al.	Jul 2010	B2
7758625	Wu et al.	Jul 2010	B2
7763065	Schmid et al.	Jul 2010	B2
7780725	Haug et al.	Aug 2010	B2
7780726	Seguin	Aug 2010	B2
7799065	Pappas	Sep 2010	B2
7803185	Gabbay	Sep 2010	B2
7824442	Salahieh et al.	Nov 2010	B2
7824443	Salahieh et al.	Nov 2010	B2
7833262	McGuckin et al.	Nov 2010	B2
7837727	Goetz et al.	Nov 2010	B2
7846203	Cribier	Dec 2010	B2
7846204	Letac et al.	Dec 2010	B2
7857845	Stacchino et al.	Dec 2010	B2
7892292	Stack et al.	Feb 2011	B2
7896915	Guyenot et al.	Mar 2011	B2
7914574	Schmid et al.	Mar 2011	B2
7914575	Guyenot et al.	Mar 2011	B2
7918880	Austin	Apr 2011	B2
7927363	Perouse	Apr 2011	B2
7938851	Olson et al.	May 2011	B2
7947071	Schmid et al.	May 2011	B2
7947075	Goetz et al.	May 2011	B2
7959666	Salahieh et al.	Jun 2011	B2
7959672	Salahieh et al.	Jun 2011	B2
7967853	Eidenschink et al.	Jun 2011	B2
7988724	Salahieh et al.	Aug 2011	B2
8002825	Letac et al.	Aug 2011	B2
8048153	Salahieh et al.	Nov 2011	B2
8052749	Salahieh et al.	Nov 2011	B2
8057540	Letac et al.	Nov 2011	B2
8092518	Schreck	Jan 2012	B2
8092520	Quadri	Jan 2012	B2
8136659	Salahieh et al.	Mar 2012	B2
8157853	Laske et al.	Apr 2012	B2
8167894	Miles et al.	May 2012	B2
8172896	McNamara et al.	May 2012	B2
8182528	Salahieh et al.	May 2012	B2
8192351	Fishler et al.	Jun 2012	B2
8226710	Nguyen et al.	Jul 2012	B2
8231670	Salahieh et al.	Jul 2012	B2
8236049	Rowe et al.	Aug 2012	B2
8246678	Salahieh et al.	Aug 2012	B2
8252051	Chau et al.	Aug 2012	B2
8252052	Salahieh et al.	Aug 2012	B2
8277500	Schmid et al.	Oct 2012	B2
8287584	Salahieh et al.	Oct 2012	B2
8308798	Pintor et al.	Nov 2012	B2
8317858	Straubinger et al.	Nov 2012	B2
8323335	Rowe et al.	Dec 2012	B2
8328868	Paul et al.	Dec 2012	B2
8343213	Salahieh et al.	Jan 2013	B2
8348999	Kheradvar et al.	Jan 2013	B2
8366767	Zhang	Feb 2013	B2
8376865	Forster et al.	Feb 2013	B2
8377117	Keidar et al.	Feb 2013	B2
8398708	Meiri et al.	Mar 2013	B2
8403983	Quadri et al.	Mar 2013	B2
8414644	Quadri et al.	Apr 2013	B2
8414645	Dwork et al.	Apr 2013	B2
8512394	Schmid et al.	Aug 2013	B2
8523936	Schmid et al.	Sep 2013	B2
8540762	Schmid et al.	Sep 2013	B2
8545547	Schmid et al.	Oct 2013	B2
8579962	Salahieh et al.	Nov 2013	B2
8603159	Seguin et al.	Dec 2013	B2
8603160	Salahieh et al.	Dec 2013	B2
8617235	Schmid et al.	Dec 2013	B2
8617236	Paul et al.	Dec 2013	B2
8623074	Ryan	Jan 2014	B2
8623076	Salahieh et al.	Jan 2014	B2
8623078	Salahieh et al.	Jan 2014	B2
8628571	Hacohen et al.	Jan 2014	B1
8647381	Essinger et al.	Feb 2014	B2
8668733	Haug et al.	Mar 2014	B2
8696743	Holecek et al.	Apr 2014	B2
8828078	Salahieh et al.	Sep 2014	B2
8840662	Salahieh et al.	Sep 2014	B2
8840663	Salahieh et al.	Sep 2014	B2
8845721	Braido et al.	Sep 2014	B2
8858620	Salahieh et al.	Oct 2014	B2
8894703	Salahieh et al.	Nov 2014	B2
8951299	Paul et al.	Feb 2015	B2
8992608	Haug et al.	Mar 2015	B2
9005273	Salahieh et al.	Apr 2015	B2
9011521	Haug et al.	Apr 2015	B2
9168131	Yohanan et al.	Oct 2015	B2
20010002445	Vesely	May 2001	A1
20010007956	Letac et al.	Jul 2001	A1
20010010017	Letac et al.	Jul 2001	A1
20010021872	Bailey et al.	Sep 2001	A1
20010025196	Chinn et al.	Sep 2001	A1
20010027338	Greenberg	Oct 2001	A1
20010032013	Marton	Oct 2001	A1
20010039450	Pavcnik et al.	Nov 2001	A1
20010041928	Pavcnik et al.	Nov 2001	A1
20010041930	Globerman et al.	Nov 2001	A1
20010044634	Michael et al.	Nov 2001	A1
20010044652	Moore	Nov 2001	A1
20010044656	Williamson et al.	Nov 2001	A1
20020002396	Fulkerson	Jan 2002	A1
20020010489	Grayzel et al.	Jan 2002	A1
20020026233	Shaknovich	Feb 2002	A1
20020029014	Jayaraman	Mar 2002	A1
20020029981	Nigam	Mar 2002	A1
20020032480	Spence et al.	Mar 2002	A1
20020032481	Gabbay	Mar 2002	A1
20020042651	Liddicoat et al.	Apr 2002	A1
20020052651	Myers et al.	May 2002	A1
20020055767	Forde et al.	May 2002	A1
20020055769	Wang	May 2002	A1
20020055774	Liddicoat	May 2002	A1
20020058987	Butaric et al.	May 2002	A1
20020058995	Stevens	May 2002	A1
20020077696	Zadno-Azizi et al.	Jun 2002	A1
20020082609	Green	Jun 2002	A1
20020095173	Mazzocchi et al.	Jul 2002	A1
20020095209	Zadno-Azizi et al.	Jul 2002	A1
20020111674	Chouinard et al.	Aug 2002	A1
20020120328	Pathak et al.	Aug 2002	A1
20020123790	White et al.	Sep 2002	A1
20020123802	Snyders	Sep 2002	A1
20020138138	Yang	Sep 2002	A1
20020151970	Garrison et al.	Oct 2002	A1
20020156522	Ivancev et al.	Oct 2002	A1
20020161390	Mouw	Oct 2002	A1
20020161392	Dubrul	Oct 2002	A1
20020161394	Macoviak et al.	Oct 2002	A1
20020165576	Boyle et al.	Nov 2002	A1
20020177766	Mogul	Nov 2002	A1
20020177894	Acosta et al.	Nov 2002	A1
20020183781	Casey et al.	Dec 2002	A1
20020188341	Elliott	Dec 2002	A1
20020188344	Bolea et al.	Dec 2002	A1
20020193871	Beyersdorf et al.	Dec 2002	A1
20030014104	Cribier	Jan 2003	A1
20030023300	Bailey et al.	Jan 2003	A1
20030023303	Palmaz et al.	Jan 2003	A1
20030027332	Lafrance et al.	Feb 2003	A1
20030028213	Thill et al.	Feb 2003	A1
20030028247	Cali	Feb 2003	A1
20030036791	Philipp et al.	Feb 2003	A1
20030036795	Andersen et al.	Feb 2003	A1
20030040736	Stevens et al.	Feb 2003	A1
20030040771	Hyodoh et al.	Feb 2003	A1
20030040772	Hyodoh et al.	Feb 2003	A1
20030040791	Oktay	Feb 2003	A1
20030040792	Gabbay	Feb 2003	A1
20030042186	Boyle	Mar 2003	A1
20030050694	Yang et al.	Mar 2003	A1
20030055495	Pease et al.	Mar 2003	A1
20030057156	Peterson et al.	Mar 2003	A1
20030060844	Borillo et al.	Mar 2003	A1
20030065386	Weadock	Apr 2003	A1
20030069492	Abrams et al.	Apr 2003	A1
20030069646	Stinson	Apr 2003	A1
20030070944	Nigam	Apr 2003	A1
20030074058	Sherry	Apr 2003	A1
20030093145	Lawrence-Brown et al.	May 2003	A1
20030100918	Duane	May 2003	A1
20030100919	Hopkins et al.	May 2003	A1
20030109924	Cribier	Jun 2003	A1
20030109930	Bluni et al.	Jun 2003	A1
20030114912	Sequin et al.	Jun 2003	A1
20030114913	Spenser et al.	Jun 2003	A1
20030125795	Pavcnik et al.	Jul 2003	A1
20030130729	Paniagua et al.	Jul 2003	A1
20030135257	Taheri	Jul 2003	A1
20030139796	Sequin et al.	Jul 2003	A1
20030139803	Sequin et al.	Jul 2003	A1
20030144732	Cosgrove et al.	Jul 2003	A1
20030149475	Hyodoh et al.	Aug 2003	A1
20030149476	Damm et al.	Aug 2003	A1
20030149478	Figulla et al.	Aug 2003	A1
20030153974	Spenser et al.	Aug 2003	A1
20030165352	Ibrahim et al.	Sep 2003	A1
20030171803	Shimon	Sep 2003	A1
20030176884	Berrada et al.	Sep 2003	A1
20030181850	Diamond et al.	Sep 2003	A1
20030187495	Cully et al.	Oct 2003	A1
20030191516	Weldon et al.	Oct 2003	A1
20030195609	Berenstein et al.	Oct 2003	A1
20030199759	Richard	Oct 2003	A1
20030199913	Dubrul et al.	Oct 2003	A1
20030199971	Tower et al.	Oct 2003	A1
20030199972	Zadno-Azizi et al.	Oct 2003	A1
20030204249	Letort	Oct 2003	A1
20030208224	Broome	Nov 2003	A1
20030212429	Keegan et al.	Nov 2003	A1
20030212452	Zadno-Azizi et al.	Nov 2003	A1
20030212454	Scott et al.	Nov 2003	A1
20030216774	Larson	Nov 2003	A1
20030225445	Derus et al.	Dec 2003	A1
20030229390	Ashton et al.	Dec 2003	A1
20030233117	Adams et al.	Dec 2003	A1
20030236567	Elliot	Dec 2003	A1
20040004926	Maeda	Jan 2004	A1
20040006380	Buck et al.	Jan 2004	A1
20040019374	Hojeibane et al.	Jan 2004	A1
20040033364	Spiridigliozzi et al.	Feb 2004	A1
20040034411	Quijano et al.	Feb 2004	A1
20040039436	Spenser et al.	Feb 2004	A1
20040044361	Frazier et al.	Mar 2004	A1
20040044400	Cheng et al.	Mar 2004	A1
20040049224	Buehlmann et al.	Mar 2004	A1
20040049226	Keegan et al.	Mar 2004	A1
20040049262	Obermiller et al.	Mar 2004	A1
20040049266	Anduiza et al.	Mar 2004	A1
20040059407	Escamilla et al.	Mar 2004	A1
20040059409	Stenzel	Mar 2004	A1
20040073198	Gilson et al.	Apr 2004	A1
20040073289	Hartley	Apr 2004	A1
20040082904	Houde et al.	Apr 2004	A1
20040082967	Broome et al.	Apr 2004	A1
20040082989	Cook et al.	Apr 2004	A1
20040087982	Eskuri	May 2004	A1
20040088045	Cox	May 2004	A1
20040093016	Root et al.	May 2004	A1
20040093060	Seguin et al.	May 2004	A1
20040093063	Wright et al.	May 2004	A1
20040097788	Mourlas et al.	May 2004	A1
20040098022	Barone	May 2004	A1
20040098098	McGuckin et al.	May 2004	A1
20040098099	McCullagh et al.	May 2004	A1
20040098112	DiMatteo et al.	May 2004	A1
20040106976	Bailey et al.	Jun 2004	A1
20040107004	Levine et al.	Jun 2004	A1
20040111096	Tu et al.	Jun 2004	A1
20040116951	Rosengart	Jun 2004	A1
20040116999	Ledergerber	Jun 2004	A1
20040117004	Osborne et al.	Jun 2004	A1
20040117009	Cali et al.	Jun 2004	A1
20040122468	Yodfat et al.	Jun 2004	A1
20040122516	Fogarty et al.	Jun 2004	A1
20040127936	Salahieh et al.	Jul 2004	A1
20040127979	Wilson et al.	Jul 2004	A1
20040133274	Webler et al.	Jul 2004	A1
20040138694	Tran et al.	Jul 2004	A1
20040138742	Myers et al.	Jul 2004	A1
20040138743	Myers et al.	Jul 2004	A1
20040148018	Carpentier et al.	Jul 2004	A1
20040148021	Cartledge et al.	Jul 2004	A1
20040153094	Dunfee et al.	Aug 2004	A1
20040153145	Simionescu et al.	Aug 2004	A1
20040158277	Lowe et al.	Aug 2004	A1
20040167565	Beulke et al.	Aug 2004	A1
20040167620	Ortiz et al.	Aug 2004	A1
20040181140	Falwell et al.	Sep 2004	A1
20040186558	Pavcnik et al.	Sep 2004	A1
20040186563	Lobbi	Sep 2004	A1
20040193244	Hartley et al.	Sep 2004	A1
20040193261	Berreklouw	Sep 2004	A1
20040197695	Aono	Oct 2004	A1
20040199245	Lauterjung	Oct 2004	A1
20040204755	Robin	Oct 2004	A1
20040210301	Obermiller	Oct 2004	A1
20040210304	Seguin et al.	Oct 2004	A1
20040210306	Quijano et al.	Oct 2004	A1
20040210307	Khairkhahan	Oct 2004	A1
20040215331	Chew et al.	Oct 2004	A1
20040215333	Duran et al.	Oct 2004	A1
20040215339	Drasler et al.	Oct 2004	A1
20040220655	Swanson et al.	Nov 2004	A1
20040225321	Krolik et al.	Nov 2004	A1
20040225353	McGuckin et al.	Nov 2004	A1
20040225354	Allen et al.	Nov 2004	A1
20040225355	Stevens	Nov 2004	A1
20040236411	Sarac et al.	Nov 2004	A1
20040243221	Fawzi et al.	Dec 2004	A1
20040254594	Alfaro	Dec 2004	A1
20040254636	Flagle et al.	Dec 2004	A1
20040260389	Case et al.	Dec 2004	A1
20040260390	Sarac et al.	Dec 2004	A1
20050009000	Wilhelm et al.	Jan 2005	A1
20050010287	Macoviak et al.	Jan 2005	A1
20050021136	Xie et al.	Jan 2005	A1
20050033220	Wilk et al.	Feb 2005	A1
20050033398	Seguin	Feb 2005	A1
20050033402	Cully et al.	Feb 2005	A1
20050043711	Corcoran et al.	Feb 2005	A1
20050043757	Arad et al.	Feb 2005	A1
20050043759	Chanduszko	Feb 2005	A1
20050043790	Seguin	Feb 2005	A1
20050049692	Numamoto et al.	Mar 2005	A1
20050049696	Siess et al.	Mar 2005	A1
20050055088	Liddicoat et al.	Mar 2005	A1
20050060016	Wu et al.	Mar 2005	A1
20050060029	Le et al.	Mar 2005	A1
20050065594	DiMatteo et al.	Mar 2005	A1
20050070794	Deal et al.	Mar 2005	A1
20050070957	Das	Mar 2005	A1
20050075584	Cali	Apr 2005	A1
20050075662	Pedersen et al.	Apr 2005	A1
20050075712	Biancucci et al.	Apr 2005	A1
20050075717	Nguyen et al.	Apr 2005	A1
20050075719	Bergheim	Apr 2005	A1
20050075724	Svanidze et al.	Apr 2005	A1
20050075725	Rowe	Apr 2005	A1
20050075730	Myers et al.	Apr 2005	A1
20050075731	Artof et al.	Apr 2005	A1
20050075776	Cho	Apr 2005	A1
20050085841	Eversull et al.	Apr 2005	A1
20050085842	Eversull et al.	Apr 2005	A1
20050085843	Opolski et al.	Apr 2005	A1
20050085890	Rasmussen et al.	Apr 2005	A1
20050090846	Pedersen et al.	Apr 2005	A1
20050090890	Wu et al.	Apr 2005	A1
20050096692	Linder et al.	May 2005	A1
20050096726	Sequin et al.	May 2005	A1
20050096734	Majercak et al.	May 2005	A1
20050096735	Hojeibane et al.	May 2005	A1
20050096736	Osse et al.	May 2005	A1
20050096738	Cali et al.	May 2005	A1
20050098547	Cali et al.	May 2005	A1
20050100580	Osborne et al.	May 2005	A1
20050107822	WasDyke	May 2005	A1
20050113910	Paniagua et al.	May 2005	A1
20050119728	Sarac	Jun 2005	A1
20050119736	Zilla et al.	Jun 2005	A1
20050131438	Cohn	Jun 2005	A1
20050137681	Shoemaker et al.	Jun 2005	A1
20050137683	Hezi-Yamit et al.	Jun 2005	A1
20050137686	Salahieh et al.	Jun 2005	A1
20050137687	Salahieh et al.	Jun 2005	A1
20050137688	Salahieh et al.	Jun 2005	A1
20050137689	Salahieh et al.	Jun 2005	A1
20050137690	Salahieh et al.	Jun 2005	A1
20050137691	Salahieh et al.	Jun 2005	A1
20050137692	Haug et al.	Jun 2005	A1
20050137693	Haug et al.	Jun 2005	A1
20050137694	Haug et al.	Jun 2005	A1
20050137695	Salahieh et al.	Jun 2005	A1
20050137696	Salahieh et al.	Jun 2005	A1
20050137697	Salahieh et al.	Jun 2005	A1
20050137698	Salahieh et al.	Jun 2005	A1
20050137699	Salahieh et al.	Jun 2005	A1
20050137701	Salahieh et al.	Jun 2005	A1
20050137702	Haug et al.	Jun 2005	A1
20050138689	Aukerman	Jun 2005	A1
20050143804	Haverkost	Jun 2005	A1
20050143807	Pavcnik et al.	Jun 2005	A1
20050143809	Salahieh et al.	Jun 2005	A1
20050149159	Andreas et al.	Jul 2005	A1
20050149166	Schaeffer et al.	Jul 2005	A1
20050150775	Zhang et al.	Jul 2005	A1
20050165352	Henry et al.	Jul 2005	A1
20050165477	Anduiza et al.	Jul 2005	A1
20050165479	Drews et al.	Jul 2005	A1
20050171597	Boatman et al.	Aug 2005	A1
20050171598	Schaeffer	Aug 2005	A1
20050182483	Osborne et al.	Aug 2005	A1
20050182486	Gabbay	Aug 2005	A1
20050197694	Pai et al.	Sep 2005	A1
20050197695	Stacchino et al.	Sep 2005	A1
20050203549	Realyvasquez	Sep 2005	A1
20050203614	Forster et al.	Sep 2005	A1
20050203615	Forster et al.	Sep 2005	A1
20050203616	Cribier	Sep 2005	A1
20050203617	Forster et al.	Sep 2005	A1
20050203618	Sharkawy et al.	Sep 2005	A1
20050203818	Rotman et al.	Sep 2005	A9
20050209580	Freyman	Sep 2005	A1
20050222668	Schaeffer et al.	Oct 2005	A1
20050222674	Paine	Oct 2005	A1
20050228472	Case et al.	Oct 2005	A1
20050228495	Macoviak	Oct 2005	A1
20050234546	Nugent et al.	Oct 2005	A1
20050240200	Bergheim	Oct 2005	A1
20050240262	White	Oct 2005	A1
20050251250	Verhoeven et al.	Nov 2005	A1
20050251251	Cribier	Nov 2005	A1
20050261759	Lambrecht et al.	Nov 2005	A1
20050267523	Devellian et al.	Dec 2005	A1
20050267560	Bates	Dec 2005	A1
20050283231	Haug et al.	Dec 2005	A1
20050283962	Boudjemline	Dec 2005	A1
20050288706	Widomski et al.	Dec 2005	A1
20060004439	Spenser et al.	Jan 2006	A1
20060004442	Spenser et al.	Jan 2006	A1
20060015168	Gunderson	Jan 2006	A1
20060025857	Bergheim et al.	Feb 2006	A1
20060047343	Oviaff et al.	Mar 2006	A1
20060058864	Schaeffer et al.	Mar 2006	A1
20060058872	Salahieh et al.	Mar 2006	A1
20060074484	Huber	Apr 2006	A1
20060111770	Pavcnik et al.	May 2006	A1
20060122692	Gilad et al.	Jun 2006	A1
20060142846	Pavcnik et al.	Jun 2006	A1
20060149360	Schwammenthal	Jul 2006	A1
20060155312	Levine et al.	Jul 2006	A1
20060155366	LaDuca et al.	Jul 2006	A1
20060161248	Case et al.	Jul 2006	A1
20060161249	Realyvasquez et al.	Jul 2006	A1
20060173524	Salahieh et al.	Aug 2006	A1
20060178740	Stacchino et al.	Aug 2006	A1
20060190070	Dieck et al.	Aug 2006	A1
20060193885	Leonard Neethling et al.	Aug 2006	A1
20060195183	Navia et al.	Aug 2006	A1
20060210597	Hiles	Sep 2006	A1
20060224183	Freudenthal	Oct 2006	A1
20060229718	Marquez	Oct 2006	A1
20060246584	Covelli	Nov 2006	A1
20060253191	Salahieh et al.	Nov 2006	A1
20060259134	Schwammenthal et al.	Nov 2006	A1
20060259136	Nguyen et al.	Nov 2006	A1
20060259137	Artof et al.	Nov 2006	A1
20060265056	Nguyen et al.	Nov 2006	A1
20060270958	Eorge	Nov 2006	A1
20060271166	Thill et al.	Nov 2006	A1
20060287668	Fawzi et al.	Dec 2006	A1
20060287717	Owe et al.	Dec 2006	A1
20060287719	Owe et al.	Dec 2006	A1
20060290027	O'Connor et al.	Dec 2006	A1
20060293745	Carpentier et al.	Dec 2006	A1
20070005129	Damm et al.	Jan 2007	A1
20070005131	Taylor	Jan 2007	A1
20070005132	Simionescu et al.	Jan 2007	A1
20070010876	Salahieh et al.	Jan 2007	A1
20070010877	Salahieh et al.	Jan 2007	A1
20070016286	Herrmann et al.	Jan 2007	A1
20070020248	Everaerts et al.	Jan 2007	A1
20070021826	Case et al.	Jan 2007	A1
20070027535	Purdy et al.	Feb 2007	A1
20070038291	Case et al.	Feb 2007	A1
20070038295	Case et al.	Feb 2007	A1
20070043435	Seguin et al.	Feb 2007	A1
20070050014	Johnson	Mar 2007	A1
20070055340	Pryor	Mar 2007	A1
20070060998	Butterwick et al.	Mar 2007	A1
20070061002	Paul et al.	Mar 2007	A1
20070061008	Salahieh et al.	Mar 2007	A1
20070088431	Bourang et al.	Apr 2007	A1
20070093887	Case et al.	Apr 2007	A1
20070100427	Perouse	May 2007	A1
20070100435	Case et al.	May 2007	A1
20070100440	Figulla et al.	May 2007	A1
20070112355	Salahieh et al.	May 2007	A1
20070112422	Dehdashtian	May 2007	A1
20070118214	Salahieh et al.	May 2007	A1
20070123700	Ueda et al.	May 2007	A1
20070123979	Perier et al.	May 2007	A1
20070142906	Figulla et al.	Jun 2007	A1
20070142907	Moaddeb et al.	Jun 2007	A1
20070162103	Case et al.	Jul 2007	A1
20070162107	Haug et al.	Jul 2007	A1
20070173918	Dreher et al.	Jul 2007	A1
20070173932	Cali et al.	Jul 2007	A1
20070179592	Schaeffer	Aug 2007	A1
20070179600	Vardi	Aug 2007	A1
20070198097	Zegdi	Aug 2007	A1
20070203503	Salahieh et al.	Aug 2007	A1
20070203576	Lee et al.	Aug 2007	A1
20070213813	Von Segesser et al.	Sep 2007	A1
20070239265	Birdsall	Oct 2007	A1
20070239269	Dolan et al.	Oct 2007	A1
20070239271	Nguyen	Oct 2007	A1
20070244543	Mitchell	Oct 2007	A1
20070244546	Francis	Oct 2007	A1
20070244551	Stobie	Oct 2007	A1
20070244552	Salahieh et al.	Oct 2007	A1
20070260327	Case et al.	Nov 2007	A1
20070282436	Pinchuk	Dec 2007	A1
20070288087	Fearnot et al.	Dec 2007	A1
20070288089	Gurskis et al.	Dec 2007	A1
20080009940	Cribier	Jan 2008	A1
20080021546	Patz et al.	Jan 2008	A1
20080033534	Cook et al.	Feb 2008	A1
20080033541	Gelbart et al.	Feb 2008	A1
20080065011	Marchand et al.	Mar 2008	A1
20080071361	Tuval et al.	Mar 2008	A1
20080071362	Tuval et al.	Mar 2008	A1
20080071363	Tuval et al.	Mar 2008	A1
20080071366	Tuval et al.	Mar 2008	A1
20080071368	Tuval et al.	Mar 2008	A1
20080077234	Styrc	Mar 2008	A1
20080077236	Letac et al.	Mar 2008	A1
20080082165	Wilson et al.	Apr 2008	A1
20080086205	Gordy et al.	Apr 2008	A1
20080097586	Pavcnik et al.	Apr 2008	A1
20080102439	Tian et al.	May 2008	A1
20080125859	Salahieh et al.	May 2008	A1
20080133003	Seguin et al.	Jun 2008	A1
20080140189	Nguyen et al.	Jun 2008	A1
20080154355	Benichou et al.	Jun 2008	A1
20080161909	Kheradvar et al.	Jul 2008	A1
20080177381	Navia et al.	Jul 2008	A1
20080188928	Salahieh et al.	Aug 2008	A1
20080195199	Kheradvar et al.	Aug 2008	A1
20080200977	Paul et al.	Aug 2008	A1
20080208327	Rowe	Aug 2008	A1
20080208328	Antocci et al.	Aug 2008	A1
20080208332	Lamphere et al.	Aug 2008	A1
20080215143	Seguin	Sep 2008	A1
20080221672	Lamphere et al.	Sep 2008	A1
20080228263	Ryan	Sep 2008	A1
20080234814	Salahieh et al.	Sep 2008	A1
20080255660	Guyenot et al.	Oct 2008	A1
20080255661	Straubinger et al.	Oct 2008	A1
20080262602	Wilk et al.	Oct 2008	A1
20080269878	Iobbi	Oct 2008	A1
20080275549	Rowe	Nov 2008	A1
20080275550	Kheradvar et al.	Nov 2008	A1
20080288054	Putney et al.	Nov 2008	A1
20090005863	Goetz et al.	Jan 2009	A1
20090030512	Thielen et al.	Jan 2009	A1
20090054969	Salahieh et al.	Feb 2009	A1
20090076598	Salahieh et al.	Mar 2009	A1
20090093877	Keidar et al.	Apr 2009	A1
20090164006	Seguin et al.	Jun 2009	A1
20090171432	Von Segesser et al.	Jul 2009	A1
20090171447	Von Segesser et al.	Jul 2009	A1
20090171456	Kveen et al.	Jul 2009	A1
20090216312	Straubinger et al.	Aug 2009	A1
20090222076	Figulla et al.	Sep 2009	A1
20090264759	Byrd	Oct 2009	A1
20090264997	Salahieh et al.	Oct 2009	A1
20090276040	Rowe et al.	Nov 2009	A1
20090287299	Tabor et al.	Nov 2009	A1
20090299462	Fawzi et al.	Dec 2009	A1
20100036479	Hill et al.	Feb 2010	A1
20100049313	Alon et al.	Feb 2010	A1
20100082089	Quadri et al.	Apr 2010	A1
20100094399	Dorn et al.	Apr 2010	A1
20100121434	Paul et al.	May 2010	A1
20100161045	Righini	Jun 2010	A1
20100168839	Braido et al.	Jul 2010	A1
20100185275	Richter et al.	Jul 2010	A1
20100191320	Straubinger et al.	Jul 2010	A1
20100191326	Alkhatib	Jul 2010	A1
20100219092	Salahieh et al.	Sep 2010	A1
20100239917	Lee et al.	Sep 2010	A1
20100249908	Chau et al.	Sep 2010	A1
20100249915	Zhang	Sep 2010	A1
20100249916	Zhang	Sep 2010	A1
20100249918	Zhang	Sep 2010	A1
20100268332	Tuval et al.	Oct 2010	A1
20100280495	Paul et al.	Nov 2010	A1
20100298931	Quadri et al.	Nov 2010	A1
20110022157	Essinger et al.	Jan 2011	A1
20110029066	Gilad et al.	Feb 2011	A1
20110040366	Goetz et al.	Feb 2011	A1
20110040374	Goetz et al.	Feb 2011	A1
20110098805	Dwork et al.	Apr 2011	A1
20110224780	Tabor et al.	Sep 2011	A1
20110257735	Salahieh et al.	Oct 2011	A1
20110264191	Rothstein	Oct 2011	A1
20110264196	Savage et al.	Oct 2011	A1
20110264203	Dwork et al.	Oct 2011	A1
20110276129	Salahieh et al.	Nov 2011	A1
20110288634	Tuval et al.	Nov 2011	A1
20110295363	Girard et al.	Dec 2011	A1
20110319989	Lane et al.	Dec 2011	A1
20120016469	Salahieh et al.	Jan 2012	A1
20120016471	Salahieh et al.	Jan 2012	A1
20120022633	Olson et al.	Jan 2012	A1
20120022642	Haug et al.	Jan 2012	A1
20120029627	Salahieh et al.	Feb 2012	A1
20120041549	Salahieh et al.	Feb 2012	A1
20120041550	Salahieh et al.	Feb 2012	A1
20120046740	Paul et al.	Feb 2012	A1
20120053683	Salahieh et al.	Mar 2012	A1
20120089224	Haug et al.	Apr 2012	A1
20120101571	Thambar et al.	Apr 2012	A1
20120101572	Kovalsky et al.	Apr 2012	A1
20120116496	Chuter et al.	May 2012	A1
20120123529	Levi et al.	May 2012	A1
20120132547	Salahieh et al.	May 2012	A1
20120172982	Stacchino et al.	Jul 2012	A1
20120179244	Schankereli et al.	Jul 2012	A1
20120197379	Laske et al.	Aug 2012	A1
20120303113	Benichou et al.	Nov 2012	A1
20120303116	Gorman, III et al.	Nov 2012	A1
20120330409	Haug et al.	Dec 2012	A1
20130013057	Salahieh et al.	Jan 2013	A1
20130018457	Gregg et al.	Jan 2013	A1
20130030520	Lee et al.	Jan 2013	A1
20130079867	Hoffman et al.	Mar 2013	A1
20130079869	Straubinger et al.	Mar 2013	A1
20130096664	Goetz et al.	Apr 2013	A1
20130123796	Sutton et al.	May 2013	A1
20130138207	Quadri et al.	May 2013	A1
20130158656	Sutton et al.	Jun 2013	A1
20130166017	Cartledge et al.	Jun 2013	A1
20130184813	Quadri et al.	Jul 2013	A1
20130190865	Anderson	Jul 2013	A1
20130253640	Meiri et al.	Sep 2013	A1
20130289698	Wang et al.	Oct 2013	A1
20130296999	Burriesci et al.	Nov 2013	A1
20130304199	Sutton et al.	Nov 2013	A1
20130310917	Richter et al.	Nov 2013	A1
20130310923	Kheradvar et al.	Nov 2013	A1
20140018911	Zhou et al.	Jan 2014	A1
20140094904	Salahieh et al.	Apr 2014	A1
20140114405	Paul et al.	Apr 2014	A1
20140114406	Salahieh et al.	Apr 2014	A1
20140121766	Salahieh et al.	May 2014	A1
20140135912	Salahieh et al.	May 2014	A1
20140243967	Salahieh et al.	Aug 2014	A1
20150012085	Salahieh et al.	Jan 2015	A1
20150073540	Salahieh et al.	Mar 2015	A1
20150073541	Salahieh et al.	Mar 2015	A1
20150127094	Salahieh et al.	May 2015	A1
20160045307	Yohanan et al.	Feb 2016	A1
20160199184	Ma et al.	Jul 2016	A1

Foreign Referenced Citations (328)

Number	Date	Country
2006328896	Jun 2007	AU
2002329324	Jul 2007	AU
2007294199	Mar 2008	AU
2009200985	Apr 2009	AU
2634358	Jun 2007	CA
2657839	Mar 2008	CA
2659690	Mar 2008	CA
1338951	Mar 2002	CN
19532846	Mar 1997	DE
19546692	Jun 1997	DE
20003874 UI	Jun 2000	DE
19857887	Jul 2000	DE
19907646	Aug 2000	DE
10049812	Apr 2002	DE
10049813	Apr 2002	DE
10049814	Apr 2002	DE
10049815	Apr 2002	DE
10121210	Nov 2002	DE
19546692	Nov 2002	DE
10335948	Feb 2005	DE
10010074	Apr 2005	DE
102005003632	Aug 2006	DE
102005051849	May 2007	DE
202007005491	Jul 2007	DE
0084395	Jul 1983	EP
0103546	May 1988	EP
0144167	Nov 1989	EP
0515324	Nov 1992	EP
579523	Jan 1994	EP
04592410	Apr 1994	EP
0657147	Jun 1995	EP
0696447	Feb 1996	EP
0409929	Apr 1997	EP
0850607	Jul 1998	EP
0778775	Jan 1999	EP
0928615	Jul 1999	EP
0943302	Sep 1999	EP
0597967	Dec 1999	EP
1000590	May 2000	EP
1057459	Dec 2000	EP
1057460	Dec 2000	EP
1078610	Feb 2001	EP
1893132	Mar 2001	EP
1088529	Apr 2001	EP
1093771	Apr 2001	EP
1158937	Dec 2001	EP
0729364	Jan 2002	EP
1164976	Jan 2002	EP
0971649	Dec 2002	EP
1262201	Dec 2002	EP
1264582	Dec 2002	EP
0937439	Sep 2003	EP
1017868	Sep 2003	EP
1340473	Sep 2003	EP
1354569	Oct 2003	EP
1041943	Mar 2004	EP
1356793	Mar 2004	EP
1401359	Mar 2004	EP
1255510	Apr 2004	EP
1042045	May 2004	EP
0819013	Jun 2004	EP
1430853	Jun 2004	EP
1435879	Jul 2004	EP
1439800	Jul 2004	EP
1452153	Sep 2004	EP
0987998	Oct 2004	EP
1469797	Oct 2004	EP
1087727	Nov 2004	EP
1472996	Nov 2004	EP
1233731	Dec 2004	EP
1229864	Apr 2005	EP
1253875	Apr 2005	EP
1251803	Jun 2005	EP
1059894	Jul 2005	EP
1551336	Jul 2005	EP
1562515	Aug 2005	EP
1570809	Sep 2005	EP
1576937	Sep 2005	EP
1267753	Oct 2005	EP
1582178	Oct 2005	EP
1582179	Oct 2005	EP
1589902	Nov 2005	EP
1598031	Nov 2005	EP
1600121	Nov 2005	EP
1156757	Dec 2005	EP
1616531	Jan 2006	EP
1690515	Aug 2006	EP
1251805	Mar 2007	EP
1251797	Nov 2007	EP
1878407	Jan 2008	EP
1886649	Feb 2008	EP
1900343	Mar 2008	EP
1435878	Apr 2008	EP
1605871	Jul 2008	EP
1968491	Sep 2008	EP
1980220	Oct 2008	EP
1994913	Nov 2008	EP
2000115	Dec 2008	EP
1255510	Mar 2009	EP
2033593	Mar 2009	EP
2047824	Apr 2009	EP
2059192	May 2009	EP
2074964	Jul 2009	EP
1441672	Sep 2011	EP
1551274	Dec 2014	EP
2749254	Jun 2015	EP
2926766	Oct 2015	EP
2788217	Jul 2000	FR
2874812	Mar 2006	FR
2056023	Mar 1981	GB
2398245	Aug 2004	GB
2433700	Dec 2007	GB
2440809	Aug 2011	GB
2003523262	Aug 2003	JP
2003524504	Aug 2003	JP
2004267750	Sep 2004	JP
2007296375	Nov 2007	JP
1904362	Mar 2012	JP
1271508	Nov 1986	SU
1371700	Feb 1988	SU
1990009102	Aug 1990	WO
9117720	Nov 1991	WO
9217118	Oct 1992	WO
9301768	Feb 1993	WO
9315693	Aug 1993	WO
9504556	Feb 1995	WO
1995011055	Apr 1995	WO
9529640	Nov 1995	WO
9614032	May 1996	WO
9624306	Aug 1996	WO
9640012	Dec 1996	WO
9748350	Dec 1997	WO
9829057	Jul 1998	WO
1998029057	Jul 1998	WO
9836790	Aug 1998	WO
9850103	Nov 1998	WO
9855047	Dec 1998	WO
9857599	Dec 1998	WO
9933414	Jul 1999	WO
9940964	Aug 1999	WO
9944542	Sep 1999	WO
9947075	Sep 1999	WO
9951165	Oct 1999	WO
1999053987	Oct 1999	WO
2000002503	Jan 2000	WO
0009059	Feb 2000	WO
2000015148	Mar 2000	WO
0135870	May 2000	WO
2000025702	May 2000	WO
2000028922	May 2000	WO
0041652	Jul 2000	WO
0044308	Aug 2000	WO
0044311	Aug 2000	WO
0044313	Aug 2000	WO
0045874	Aug 2000	WO
0049970	Aug 2000	WO
2000047139	Aug 2000	WO
2000053122	Sep 2000	WO
0067661	Nov 2000	WO
0105331	Jan 2001	WO
0106959	Feb 2001	WO
0108596	Feb 2001	WO
0110320	Feb 2001	WO
0110343	Feb 2001	WO
2001035870	May 2001	WO
0149213	Jul 2001	WO
2001049213	Jul 2001	WO
0154625	Aug 2001	WO
0162189	Aug 2001	WO
2001054625	Aug 2001	WO
2001058503	Aug 2001	WO
2001062189	Aug 2001	WO
0164137	Sep 2001	WO
2000047139	Sep 2001	WO
0176510	Oct 2001	WO
0197715	Dec 2001	WO
0236048	May 2002	WO
0241789	May 2002	WO
2002036048	May 2002	WO
0243620	Jun 2002	WO
0247575	Jun 2002	WO
02056955	Jul 2002	WO
2002058745	Aug 2002	WO
02069842	Sep 2002	WO
2002067782	Sep 2002	WO
2002076349	Oct 2002	WO
02100297	Dec 2002	WO
2002100301	Dec 2002	WO
2002102286	Dec 2002	WO
03003943	Jan 2003	WO
2003003949	Jan 2003	WO
2003007795	Jan 2003	WO
03015851	Feb 2003	WO
2003009785	Feb 2003	WO
2003011195	Feb 2003	WO
03032869	Apr 2003	WO
2003028592	Apr 2003	WO
2003030776	Apr 2003	WO
03037222	May 2003	WO
03037227	May 2003	WO
03047648	Jun 2003	WO
2003047468	Jun 2003	WO
2003063729	Aug 2003	WO
03088873	Oct 2003	WO
2003079928	Oct 2003	WO
03094793	Nov 2003	WO
03094797	Nov 2003	WO
03096932	Nov 2003	WO
2003096935	Nov 2003	WO
2004004597	Jan 2004	WO
2004006803	Jan 2004	WO
2004006804	Jan 2004	WO
2004014256	Feb 2004	WO
2004016200	Feb 2004	WO
2004016201	Feb 2004	WO
2004019817	Mar 2004	WO
2004019825	Mar 2004	WO
2004021922	Mar 2004	WO
2004023980	Mar 2004	WO
2004019811	Apr 2004	WO
2004026117	Apr 2004	WO
2004026173	Apr 2004	WO
2004028399	Apr 2004	WO
2004041126	May 2004	WO
2004043293	May 2004	WO
2004043301	May 2004	WO
2004047681	Jun 2004	WO
2004058106	Aug 2004	WO
2004066876	Aug 2004	WO
2004082527	Sep 2004	WO
2004082528	Sep 2004	WO
2004082536	Sep 2004	WO
2004089250	Oct 2004	WO
2004089253	Oct 2004	WO
2004093728	Nov 2004	WO
2004096100	Nov 2004	WO
2004105651	Dec 2004	WO
2005002466	Jan 2005	WO
2005004753	Jan 2005	WO
2005009285	Feb 2005	WO
2005011534	Feb 2005	WO
2005011535	Feb 2005	WO
2005021063	Mar 2005	WO
2005023155	Mar 2005	WO
2005027790	Mar 2005	WO
2005034812	Apr 2005	WO
2005046528	May 2005	WO
2005046529	May 2005	WO
2005048883	Jun 2005	WO
2005062980	Jul 2005	WO
2005065585	Jul 2005	WO
2005070343	Aug 2005	WO
2005072654	Aug 2005	WO
2005084595	Sep 2005	WO
2005087140	Sep 2005	WO
2005096993	Oct 2005	WO
2005102015	Nov 2005	WO
2006005015	Jan 2006	WO
2006009690	Jan 2006	WO
2006027499	Mar 2006	WO
2006058163	Jun 2006	WO
2006068944	Jun 2006	WO
2006076890	Jul 2006	WO
2006083763	Aug 2006	WO
2006086135	Aug 2006	WO
2006086736	Aug 2006	WO
2006093795	Sep 2006	WO
2006102063	Sep 2006	WO
2006108090	Oct 2006	WO
2006124649	Nov 2006	WO
2006127756	Nov 2006	WO
2006127765	Nov 2006	WO
2006132948	Dec 2006	WO
2007009117	Jan 2007	WO
2007035471	Mar 2007	WO
2006138391	Apr 2007	WO
2007044285	Apr 2007	WO
2007047488	Apr 2007	WO
2007047945	Apr 2007	WO
2007058847	May 2007	WO
2007059252	May 2007	WO
2006086736	Jun 2007	WO
2007071436	Jun 2007	WO
2007092354	Aug 2007	WO
2007097983	Aug 2007	WO
2007098232	Aug 2007	WO
2007053243	Sep 2007	WO
2007120543	Oct 2007	WO
2007071436	Nov 2007	WO
2007033093	Jan 2008	WO
2007071436	Jan 2008	WO
2008028569	Mar 2008	WO
2008035337	Mar 2008	WO
2008040555	Apr 2008	WO
2008070442	Jun 2008	WO
2008070797	Jun 2008	WO
2008079962	Jul 2008	WO
2008101083	Aug 2008	WO
2008125153	Oct 2008	WO
2008138584	Nov 2008	WO
2008150529	Dec 2008	WO
2009024859	Feb 2009	WO
2009029199	Mar 2009	WO
2009042196	Apr 2009	WO
2009045334	Apr 2009	WO
2009045338	Apr 2009	WO
2009053497	Apr 2009	WO
2009061389	May 2009	WO
2009091509	Jul 2009	WO
2010042950	Apr 2010	WO
2010045238	Apr 2010	WO
2010045297	Apr 2010	WO
2010049160	May 2010	WO
2010083558	Jul 2010	WO
2010098857	Sep 2010	WO
2011051043	May 2011	WO
2011057087	May 2011	WO
2012002228	Jan 2012	WO
2012116368	Aug 2012	WO
2012162228	Nov 2012	WO
2013009975	Jan 2013	WO
2013028387	Feb 2013	WO
2013033791	Mar 2013	WO
2013074671	May 2013	WO
2013096545	Jun 2013	WO
2013134214	Sep 2013	WO
2014072439	May 2014	WO
2016126511	Aug 2016	WO

Non-Patent Literature Citations (144)

Entry
US 8,062,356 B2, 11/2011, Salahieh et al. (withdrawn)
US 8,062,357 B2, 11/2011, Salahieh et al. (withdrawn)
US 8,075,614 B2, 12/2011, Salahieh et al. (withdrawn)
US 8,133,271 B2, 03/2012, Salahieh et al. (withdrawn)
US 8,211,170 B2, 07/2012, Paul et al. (withdrawn)
Akins et al. “Risk of Preoperative Valve Replacement for Failed Mitral and Aortic Bioprostheses”, Ann Thorac Surg (1998), 65:1545-52.
Australian Examination Report, Application No. AU 2009200985, dated Mar. 4, 2010.
Dewey et al., “Transapical aortic valve implantation: an animal feasibility study”, The annals of thoracic surgery, (2006): 82:110-116.
European Examination Report, Application No. EP07818037.9, dated Aug. 11, 2009.
European Search Report, Application No. EP09154935.2, dated May 29, 2009.
Examination Report, Application No. EP06841127.1, dated Feb. 6, 2009.
Examination Report, dated Mar. 28, 2014, for European Patent Application No. 08806901.8.
Examination Search Report, dated Oct. 30, 2014, for Canadian Application No. 2,703,665.
Hijazi et al., “Transcatheter Valve Repair” Taylor & Francis, 2006, p. 165-186.
Huber et al. “Direct Access Valve Replacement (DAVR)—are we entering a new era in cardiac surgery?” European Journal of Cardio-Thoracic Surgery, p. 380-385, Jan. 19, 2006.
Huber et al. “Direct-Access Valve Replacement: A Novel Approach for Off-Pump Valve Implantation Using Valved Stents”, Journal of the American College of Cardiology, vol. 46, No. 2, Jul. 19, 2005, p. 366-370.
International Preliminary Report on Patentability, Application No. PCT/EP 2007/07413, dated Mar. 10, 2009.
International Preliminary Report on Patentability, dated May 8, 2012, for International Application No. PCT/EP2010/063306.
International Preliminary Report, Application No. PCT/EP20061012455, dated Jun. 24, 2008.
International Search Report and Written Opinion, dated Nov. 17, 2010, for International Application No. PCT/EP2010/063306.
International Search Report for International Application No. PCT/EP2008/064558, date of completion of report, Mar. 18, 2009 and Written Opinion of the International Search Authority for International Application No. PCT/EP2008/064558.
International Search Report for PCT/EP2006/012455, dated Sep. 27, 2007.
IPRP for PCT/EP2007/007413, issued Mar. 10, 2009.
IPRP issued Mar. 26, 2013 for PCT/EP2011/066677.
IPRP issued May 8, 2012 for PCT/EP2010/063306.
IRPR for PCT/EP2010/057798, mailed Dec. 6, 2011.
IRPR for PCT/IB2008/002180,issued Feb. 24, 2010.
ISR & WO for PCT/IB2008/002180, mailed Apr. 15, 2009.
ISR for PCT/EP2007/007413, mailed Jan. 28, 2008.
ISR for PCT/EP2010/057798, mailed Sep. 12, 2010.
ISR for PCT/EP2010/063306.
ISR dated Apr. 17, 2014 for PCT/EP2013/073318.
ISR dated Feb. 17, 2012 for PCT/EP2011/066677.
Lichtenstein et al. “Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience”, Circulation, American Heart Association vol. 114; Jul. 31, 2006, p. 591-596.
Lichtenstein, Samuel V., “Closed heart surgery: Back to the future” The Journal of Thoracic and Cardiovascular Surgery, vol. 131, No. 5, 2006, p. 941-943.
Liu et al. “Effect of Fiber Orientation on the Stress Distribution within a Leaflet of a Polymer Composite Heart Valve in the Closed Position” Journal of Biomechanics. 2007 (40): 10991106.
Ma et al., “Double-crowned valved stents for off-pump mitral valve replacement”, European Journal of Cardio-Thoracic Surgery (2005), 28:194-199.
Mack, M.J., “Minimally invasive cardiac surgery”, Surg Endosc, (2006) 20:S488-S492.
Moazami et al. “Transluminal Aortic Valve Placement: a Fesibility Study with a Newly Designed Collapsible Aortic Valve”, ASAIO Journal, vol. 42; 1996.
Office Action, dated Nov. 7, 2014, for Canadian Application No. 2,703,665.
Partial International Search Report for International Application No. PCT/EP2014/055044, filed Mar. 13, 2014.
Pawelec-Wojtalk, “Closure of left ventricle perforation with the use of muscular Vsd occulder”, European Journal of Cardio-Thoracic Surgery (2005), 27:714-716.
Walther et al., “Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results”, European Journal of Cardiao-thoriacic Surgery 29 (2006), 703-708.
Webb et al. “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery”, Circulation, American Hea Association, vol. 113, Feb. 6, 2006, p. 842-850.
Weerasinghe et al., “First Redo Heart Valve Replacement: A 10-Year Analysis”, Circulation (1999), 99:655-658.
Kaiser, et al., “Surgery for Left Ventricle Outflow Obstruction: Aortic Valve Replacement and Myomectomy,” Overview of Cardiac Surgery for the Cardiologist. Springer-Verlag New York, Inc., 40-45 (1994).
Kato et al., “Traumatic Thoracic Aortic Aneurysm: Treatment with Endovascular Stent-Grafts.” Radiol., 205: 657-662 (1997).
Khonsari et al., “Cardiac Surgery: Safeguards and Pitfalls in Operative Technique.” 3d ed., 45-74 (2003).
Knudsen et al., “Catheter-implanted prosthetic heart valves.” Int'l J. of Art. Organs, 16(5): 253-262, May 1993.
Kort et al., “Minimally Invasive Aortic Valve Replacement: Echocardiographic and Clinical Results.” Am. Heart J., 142(3): 476-481, Sep. 2001.
Lawrence et al., “Percutaneous Endovascular Graft: Experimental Evaluation,” Radiology, 163(2): 357-60 (May 1987).
Levi et al., “Future of Interventional Cardiology in Pediactrics.” Current Opinion in Cardiol., 18:79-90 (2003).
Levy, “Mycobacterium Chelonei Infection of Porcine Heart Valves.” The New England Journal of Medicine, Washington DC, 297(12), Sep. 22, 1977.
Love et al., The Autogenous Tissue Heart Valve: Current Status. Journal of Cardiac Surgery, 6(4): 499-507, Mar. 1991.
Lutter et al., “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation.” J. of Thoracic and Cardio. Surg., 123(4): 768-776, Apr. 2002.
Magovern et al., “Twenty-five-Year Review of the Magovern-Cromie Sutureless Aortic Valve.” Ann. Thorac. Surg., 48: S33-4 (1989).
Maraj et al., Evaluation of Hemolysis in Patients with Prosthetic Heart Valves, Clin. Cardiol. 21, 387-392 (1998).
McKay et al., “The Mansfield Scientific Aortic Valvuloplasty Registry: Overview of Acute Hemodynamic Results and Procedural Complications.” J. Am. Coll. Cardiol. 17(2): 485-91 (Feb. 1991).
Mirich et al., “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study.” Radiology, 170: 1033-1037 (1989).
Moulopoulos et al., “Catheter-Mounted Aortic Valves.” Annals of Thoracic Surg., 11(5): 423-430, May 1971.
Paniagua et al., “Heart Watch.” Texas Heart Institute. Edition: 8 pages, Spring, 2004.
Paniagua et al., “Percutaneous Heart Valve in the Chronic In Vitro Testing Model.” Circulation, 106: e51-e52, Sep. 17, 2002.
Parodi et al., “Transfemoral Intraluminal Graft Implantation for Abdominal Aortic Aneurysms.” Ann. Vasc. Surg., 5(6):491-9 (1991).
Pavcnik et al., “Percutaneous Bioprosthetic Venous Valve: A Long-term Study in Sheep.” J. of Vascular Surg., 35(3): 598-603, Mar. 2002.
Pavcnik et al., “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement.” Radiology 183:151-54 (1992).
Pavcnik, et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Technol. 9(3/4) 287-292 (2000).
Phillips et al., “A Temporary Catheter-Tip Aortic Valve: Hemodynamic Effects on Experimental Acute Aortic nsufficiency.” Annals of Thoracic Surg., 21(2): 134-136, Feb. 1976.
Printz, et al., “Let the Blood Circulate.” Sulzer Tech. Rev. 4/99.
U.S. Appl. No. 60/553,945, Jennifer K. White, “Prosthetic Valve With Dynamic Seal”, pp. 1-43, Mar. 18, 2004.
Raillat et al., “Treatment of Iliac Artery Stenosis with the Wallstent Endoprosthesis.” AJR 154(3):613-6 (Mar. 1990).
Remadi et al., “Preliminary results of 130 aortic valve replacements with a new mechanical bileaflet prosthesis: the Edwards MIRA valve” Interactive Cardiovasc. and Thorac. Surg. 2, 80-83 (2003).
Rosch et al., “Gianturco-Rosch Expandable Z-Stents in the Treatment of Superior Vena Cava Syndrome.” Cardiovasc. Intervent. Radiol. 15: 319-327 (1992).
Schurink et al,. “Stent Attachment Site-related Endoleakage after Stent Graft Treatment: An in vitro study of the effects of graft size, stent type, and atherosclerotic wall changes.” J. Vasc. Surg., 30(4):658-67 (Oct. 1999).
Seminars in Interventional Cardiology, ed. P.W. Surruys, vol. 5 (2000).
Sochman et al., “Percutaneous Transcatheter Aortic Disc Valve Prosthesis Implantation: A Feasibility Study.” Cardiovasc. Intervent. Radiol., 23: 384-388, Sep. 2000.
Southern Lights Biomaterials Homepage, http://www.slv.co.nz/, Jan. 7, 2011.
Stanley et al., “Evaluation of Patient Selection Guidelines for Endoluminal AAA Repair With the Zenith Stent Graft: The Australasian Experience.” J. Endovasc. Ther. 8:457-464 (2001).
Stassano, “Mid-term Results of the Valve-on-Valve Technique for Bioprosthetic Failure.” European Journal of Cardiothoracic Surgery: vol. 18, 453-457, Oct. 2000.Q
Steinhoff et al., “Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits.” Circulation, 102 [suppl. III]: III-50-III-55 (2000).
Stuart, “In Heart Valves, A Brave, New Non-Surgical World.” Start-Up. Feb. 9-17, 2004.
Supplemental Search Report from EP Patent Office, EP Application No. 04815634.3, dated Aug. 19, 2011.
Supplemental Search Report from EP Patent Office, EP Application No. 05758878.2, dated Oct. 24, 2011.
Textbook of Interventional Cardiology, 2d Ed., Chapter 75: Percutaneous Expandable Prosthetic Valves (1994).
Thompson et al., “Endoluminal stent grafting of the thoracic aorta: Initial experience with the Gore Exduder,” Journal of Vascular Surgery, 1163-70 (Jun. 2002).
Topol, “Percutaneous Expandable Prosthetic Valves.” Textbook of Interventional Cardiology, W.B. Saunders Company, 2: 1268-1276, 1994.
USPTO Case IPR 2017-0006, U.S. Pat. No. 8,992,608 B2, “Final Written Decision” Mar. 23, 2018.
USPTO Case IPR2017-01293, U.S. Pat. No. 8,992,608 B, Oct. 13, 2017.
Vahanian et al., “Percutaneous Approaches to Valvular Disease.” Circulation, 109: 1572-1579, Apr. 6, 2004.
Van Herwerden et al., “Percutaneous Valve Implantation: Back to the Future?” Euro. Heart J., 23(18): 1415-1416, Sep. 2002.
VentureBeatProfiles, Claudio Argento, Jan. 7, 2010, http://venturebeatprofiles.com/person/profile/claudio-argento.
Vossoughi et al., Stent Graft Update (2000)—Kononov, Volodos, and Parodi and Palmaz Stents; Hemobahn Stent Graft.
White et al., “Endoleak as a Complication of Endoluminal Grafting of Abdominal Aortic Aneurysms: Classification, Incidence, Diagnosis, and Management.” J. Endovac. Surg., 4:152-168 (1997).
Yoshioka et al., “Self-Expanding Endovascular Graft: An Experimental Study in Dogs.” AJR 151: 673-76 (Oct. 1988).
Zhou et al., “Self-expandable Valved Stent of Large Size: Off-Bypass Implantation in Pulmonary Position.” Eur. J. Cardiothorac, 24: 212-216, Aug. 2003.
Cribier et al., “Percutaneous Transluminal Valvuloplasty of Acquired Aortic Stenosis in Elderly Patients: An Alternative to Valve Replacement?” The Lancet, 63-7 (Jan. 11, 1986).
Supplemental Search Report from EP Patent Office, EP Application No. 04813777.2, dated Aug. 19, 2011.
Laborde et al., “Percutaneous Implantation of the Corevalve Aortic Valve Prosthesis for Patients Presenting High Risk for Surgical Valve Replacement.” EuroIntervention: 472-474, Feb. 2006.
“A Matter of Size.” Triennial Review of the National Nanotechnology Initiative, The National Academies Press, Washington DC, v-13, http://www.nap.edu/catalog/11752/a-matter-of-size-triennial-review-of-the-national-nanotechnology, 2006.
“Heart Valve Materials—Bovine (cow).” Equine & Porcine Pericardium, Maverick Biosciences Pty. Lt, http://maverickbio.com/biological-medical-device-materials.php?htm. 2009.
“Pericardial Heart Valves.” Edwards Lifesciences, Cardiovascular Surgery FAQ, http://www.edwards.com/products/cardiovascularsurgeryfaq.htm, Nov. 14, 2010.
Allen et al., “What are the characteristics of the ideal endovascular graft for abdominal aortic aneurysm exclusion?” J. Endovasc. Surg., 4(2):195-202 (May 1997).
Andersen et al. “Transluminal catheter implantation of a new expandable artificial cardiac valve (the stent—valve) in the aorta and the beating heart of closed chest pigs (Abstract).” Eur. Heart J., 11 (Suppl.): 224a (1990).
Andersen et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” Euro. Heart J., 13:704-708, May 1992.
Atwood et al., “Insertion of Heart Valves by Catheterization.” Project Supervised by Prof. S. Muftu of Northeastern University 2001-2002: 36-40, May 30, 2002.
Atwood et al., “Insertion of Heart Valves by Catheterization.” the Capstone Design Course Report Mime 1501-1502. Technical Design Report Northeastern University, pp. 1-93, Nov. 5, 2007.
Bailey, “Percutaneous Expandable Prosthetic Valves, Textbook of Interventional Cardiology.” vol. 2, 2d ed. Eric J. Topol, W.B. Saunders Co. (1994).
Blum et al., “Endoluminal Stent—Grafts for Intrarenal Abdominal Aortic Aneurysms.” New Engl. J. Med., 336:13-20 (1997).
Bodnar et al., “Replacement Cardiac Valves R Chapter 13: Extinct Cardiac Valve Prostheses.” Pergamon Publishing Corporation. New York, 307-322, 1991.
Bonhoeffer et al., “Percutaneous Insertion of the Pulmonary Valve.” J. Am. Coll. Cardiol., 39:1664-9 (2002).
Bonhoeffer et al., “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study.” Circulation, 102: 813-16 (2000).
Bonhoeffer, et al., “Percutaneous replacement of pulmonary valve in a right ventricle to pulmonary-artery prosthetic conduit with valve dysfunction.” The Lancet, vol. 356, 1403-05 (Oct. 21, 2000).
Boudjemline et al., “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study.” Med Sci. Monit., vol. 8, No. 4: BR113-116, Apr. 12, 2002.
Boudjemline et al., “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs.” Euro. Heart J., 23: 1045-1049, Jul. 2002.
Boudjemline et al., “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study.” Journal of the American College of Cardiology, vol. 43(6): 1082-1087, Mar. 17, 2004.
Boudjemline et al., “Percutaneous Valve Insertion: A New Approach?” J. of Thoracic and Cardio. Surg, 125(3): 741-743, Mar. 2003.
Boudjemline et al., “Steps Toward Percutaneous Aortic Valve Replacement.” Circulation, 105: 775-778, Feb. 12, 2002.
Carpentier-Edwards PERIMOUNT Bioprosthesis (2003).
Couper, “Surgical Aspects of Prosthetic Valve Selection,” Overview of Cardiac Surgery for the Cardiologist, Springer-Verlag New York, Inc., 131-145 (1994).
Cribier et al., “Early Experience with Percutaneous Transcatheter Implantation of Heart Valve Prosthesis for the Treatment of End-Stage Inoperable Patients with Calcific Aortic Stenosis.” J. of Am. Coll. of Cardio, 43(4): 698-703, Feb. 18, 2004.
Cribier et al., “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case.” Percutaneous Valve Technologies, Inc., 16 pages, Apr. 16, 2002.
Cribier et al., “Percutaneous Transcatheter Implementation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description.” Circulation, 106: 3006-3008, Dec. 10, 2002.
Cribier et al., “Trans-Cathether Implantation of Balloon-Expandable Prosthetic Heart Valves: Early Results in an Animal Model.” Circulation [suppl. II] 104(17)II-552 (Oct. 23, 2001).
Cunanan et al., “Tissue Characterization and Calcification Potential of Commercial Bioprosthetic Heart Valves.” Ann. Thorac. Surg., S417-421, May 15, 2001.
Cunliffe et al., “Glutaraldehyde Inactivation of Exotic Animal Viruses in Swine Heart Tissue.” Applied and Environmental Microbiology, Greenport, New York, 37(5): 1044-1046, May 1979.
Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms.” New Engl. J. of Med., 331(26):1729-34 (1994).
Dalby et al., “Non-Surgical Aortic Valve Replacement” Br. J. Cardiol., 10:450-2 (2003).
Dhasmana, et al., “Factors Associated With Periprosthetic Leakage Following Primary Mitral Valve Replacement: With Special Consideration of Suture Technique.” Annals of Thorac. Surg. 35(2), 170-8 (Feb. 1983).
Diethrich, AAA Stent Grafts: Current Developments, J. Invasive Cardiol. 13(5) (2001).
Dolmatch et al., Stent Grafts: Current Clinical Practice (2000)—EVT Endograft and Talent Endoprosthesis.
Dotter, “Transluminally-Placed Coilspring Endarterial Tube Grafts,” Investigative Radiology, pp. 329-332 (1969).
Emery et al., “Replacement of the Aortic Valve in Patients Under 50 Years of Age: Long-Term Follow-Up of the St. Jude Medical Prosthesis.” Ann. Thorac. Surg., 75:1815-9 (2003).
EP Search Report for EP Application No. 06824992.9, dated Aug. 10, 2011.
Examiner's First Report on AU Patent Application No. 2011202667, dated May 17, 2012.
Ferrari et al., “Percutaneous Transvascular Aortic Valve Replacement with Self-Expanding Stent-Valve Device.” Poster from the presentation given at SMIT 2000, 12th International Conference. Sep. 5, 2000.
Fluency Vascular Stent Graft Instructions for Use (2003).
Sore Excluder Instructions for Use (2002).
Greenberg, “Abdominal Aortic Endografting: Fixation and Sealing.” J. Am. Coll. Surg. 194:1:S79-S87 (2002).
Grossi, “Impact of Minimally Invasive Valvular Heart Surgery: A Case-Control Study.” Ann. Thorac. Surg., 71:807-10 (2001).
Helmus, “Mechanical and Bioprosthetic Heart Valves in Biomaterials for Artificial Organs.” Woodhead Publishing Limited: 114-162, 2011.
Hijazi, “Transcatheter Valve Replacement: A New Era of Percutaneous Cardiac Intervention Begins.” J. of Am. College of Cardio., 43(6): 1088-1089, Mar. 17, 2004.
Hourihan et al., “Transcatheter Umbrella Closure of Valvular and Paravalvular Leaks.” JACC, Boston, Massachusetts, 20(6): 1371-1377, Nov. 15, 1992.
Huber et al., “Do Valved Stents Compromise Coronary Flow?” European Journal of Cardio-thoracic Surgery, vol. 25: 754-759, Jan. 23, 2004.
Ing, “Stents: What's Available to the Pediatric Interventional Cardiologist?” Catheterization and Cardiovascular Interventions 57:274-386 (2002).
Ionescu, et al., “Prevalence and Clinical Significance of Incidental Paraprosthetic Valvar Regurgitation: A prospective study using transesophageal echocardiography.” Heart, 89:1316-21 (2003).

Related Publications (1)

	Number	Date	Country
	20180049870 A1	Feb 2018	US

Provisional Applications (3)

Number	Date	Country
60843181	Sep 2006	US
60755590	Dec 2005	US
60753071	Dec 2005	US

Divisions (2)

	Number	Date	Country
Parent	14471731	Aug 2014	US
Child	15632149		US
Parent	11700922	Dec 2006	US
Child	13433910		US

Continuations (1)

	Number	Date	Country
Parent	13433910	Mar 2012	US
Child	14471731		US

Stent-valves for valve replacement and associated methods and systems for surgery

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Disclaimer

Abstract